Hyperplasia of prostate

N14_PROSTHYPERPLA

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule only males	226837
2. Check conditions None	226837
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — N40 Hospital discharge: ICD-9 — 600 Hospital discharge: ICD-8 — 600 Cause of death: ICD-10 — N40 Cause of death: ICD-9 — 600 Cause of death: ICD-8 — 600 2 out of 7 registries used, show all original rules.	42330
4. Check minimum number of events None	42330
5. Include endpoints None	42330
6. Filter based on genotype QC (FinnGen only)	42330

Control definitions (FinnGen only)

Control exclude: N14_MALEGEN

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: N40-N51
Name in latin: Hyperplasia prostatae

NAME	N14_PROSTHYPERPLA
CONTROL_EXCLUDE	N14_MALEGEN
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX	1
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	N40
HD_ICD_9	600
HD_ICD_8	600
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	N40
COD_ICD_9	600
COD_ICD_8	600
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Hyperplasia of prostate based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	306982	-	306982
Only index persons	237063	-	237063
Unadjusted period prevalence (%)
Whole population	8.58	-	8.58
Only index persons	9.05	-	9.05
Median age at first event (years)
Whole population	-	-	69.45
Only index persons	-	-	68.69

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	42330	-	42330
Unadjusted period prevalence (%)	18.66	-	18.66
Median age at first event (years)	68.25	-	68.25

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
4042: Matched controls
32609

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

G04CA01

ATC

alfuzosin; oral

7.9

323.0

1476

2221

KE1BE

NOMESCO Finland

Rectal ultrasound examinaiton of prostata

32.8

323.0

1460

552

KED22

NOMESCO Finland

Transurethral resection of prostate

221.1

323.0

546

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

23.0

323.0

1787

1087

G04CA02

ATC

tamsulosin; oral

8.3

323.0

2124

3827

UKC02

NOMESCO Finland

Cystoscopy

10.2

323.0

1186

1273

N40

ICD-10 Finland

Hyperplasia of prostate

16384.0

323.0

4039

1697

G04CA52

ATC

tamsulosin and dutasteride; systemic

13.3

323.0

945

729

XKD00

NOMESCO Finland

Uroflowmetry

29.4

323.0

2209

1285

R33

ICD-10 Finland

Retention of urine

13.9

306.5

577

385

G04CB02

ATC

dutasteride; oral

16.2

301.8

533

303

XJH00

NOMESCO Finland

Transanal ultrasonography

17.3

293.9

506

268

G04CB01

ATC

finasteride; oral (testosterone-5-alpha reductase inhibitors)

9.4

269.1

618

612

KE1AT

NOMESCO Finland

Biopsy of prostata with ultrasoudnguidance

6.9

209.9

591

793

R74.8

ICD-10 Finland

Abnormal levels of other serum enzymes

6.7

200.2

574

787

G04BD12

ATC

mirabegron; oral

7.9

180.2

456

516

J01MA02

ATC

ciprofloxacin; systemic

2.7

177.8

1742

7046

TKE00

NOMESCO Finland

Needle biopsy of prostate

16.2

143.1

250

132

KED33

NOMESCO Finland

Transurethral incision of prostate

50.3

138.1

179

XKD06

NOMESCO Finland

Physiologic investigation of micturition

16.8

138.1

238

121

N41.1

ICD-10 Finland

Chronic prostatitis

11.0

130.6

270

210

R35

ICD-10 Finland

Polyuria

5.8

128.5

404

610

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

5.2

127.0

444

761

R31

ICD-10 Finland

Unspecified haematuria

4.5

124.1

497

984

C61

ICD-10 Finland

Malignant neoplasm of prostate

4.3

118.7

503

1050

TKC22

NOMESCO Finland

Catheterisation instruction

17.5

118.7

201

KED52

NOMESCO Finland

Visual laser resection of prostate

342.1

114.1

124

8140/3-C61.9

ICD-O-3

Adenocarcinoma, NOS, of prostate gland

4.2

104.6

454

964

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

5.4

96.1

321

517

J01EA01

ATC

trimethoprim; systemic

4.3

94.7

394

801

R39.1

ICD-10 Finland

Other difficulties with micturition

7.0

86.0

232

282

R86.0

ICD-10 Finland

Abnormal findings in specimens from male genital organs, abnormal level of enzymes

6.5

85.9

243

316

XKC03

NOMESCO Finland

Water cystometry

16.0

85.3

149

N47

ICD-10 Finland

Redundant prepuce, phimosis and paraphimosis

24.2

84.2

128

KGH10

NOMESCO Finland

Operation for phimosis

47.5

83.5

109

N41.0

ICD-10 Finland

Acute prostatitis

7.5

74.5

191

215

WX320

NOMESCO Finland

Spinalanesthesy

2.3

69.8

780

3073

G04BD08

ATC

solifenacin; oral

5.8

67.6

207

298

N45.9

ICD-10 Finland

Orchitis, epididymitis and epididymo-orchitis without abscess

14.1

66.3

121

KE1DG

NOMESCO Finland

Very extensive MRI of prostate

8.6

64.0

150

146

U02

ICPC

Urinary frequency/urgency

5.0

62.8

218

364

U07

ICPC

Urine symptom/complaint other

6.4

62.5

179

236

N30.0

ICD-10 Finland

Acute cystitis

5.5

61.5

198

303

N41.9

ICD-10 Finland

Inflammatory disease of prostate, unspecified

8.2

56.1

134

135

N02BE01

ATC

paracetamol; systemic, rectal

1.8

55.0

3181

21790

U08

ICPC

Urinary retention

14.1

54.4

N32.0

ICD-10 Finland

Bladder-neck obstruction

17.9

51.2

XKD03

NOMESCO Finland

Urethral pressure profilometry

20.2

50.8

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

3.6

50.6

254

602

N43.4

ICD-10 Finland

Spermatocele

12.5

49.1

U05

ICPC

Urination problems other

5.8

49.0

149

213

KE1BG

NOMESCO Finland

MRI of prostate

10.5

48.7

101

N42.9

ICD-10 Finland

Disorder of prostate, unspecified

10.6

48.3

100

R30.0

ICD-10 Finland

Dysuria

5.5

47.1

151

230

A02BC05

ATC

esomeprazole; systemic

1.7

46.1

1443

8107

60500

ICD-8 Finland

Redundant prepuce and phimosis, Phimosis

+∞

46.1

KF8AE

NOMESCO Finland

Ultrasound examination of scrotum

6.9

46.0

123

148

J01MA12

ATC

levofloxacin; systemic

2.0

44.8

650

2817

Y06

ICPC

Prostate symptom/complaint

5.4

44.1

143

221

KFD20

NOMESCO Finland

Excision of hydrocele of testis

382.0

43.5

KEC01

NOMESCO Finland

Percutaneous endoscopic radical prostatectomy

3.6

43.3

212

492

N43.3

ICD-10 Finland

Hydrocele, unspecified

15.8

43.3

SPAT1167

SPAT

Insertion of urinary catheter

7.4

42.4

108

121

TKC20

NOMESCO Finland

Catheterisation of bladder

3.1

41.5

251

684

Y85

ICPC

Benign prostatic hypertrophy

12.8

41.4

KE1CG

NOMESCO Finland

Extensive MRI of prostate

10.8

40.7

N32.82

ICD-10 Finland

Instability of the detrusor vesicae muscle

11.5

40.5

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.9

39.9

755

3598

SPAT1263

SPAT

Sampling

1.7

39.4

1202

6633

A02BC02

ATC

pantoprazole; systemic

1.6

38.6

2259

14654

WX408

NOMESCO Finland

General anesthesy, balanced

1.7

38.0

965

5043

KDV10

NOMESCO Finland

Internal urethrotomy

19.6

37.5

XKW99

NOMESCO Finland

Other physiological examination of urinary or male genital system

14.4

37.5

G04BD11

ATC

fesoterodine; oral

8.3

37.4

N46

ICD-10 Finland

Male infertility

324.1

36.8

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.7

36.6

977

5169

KED76

NOMESCO Finland

TUVP

167.0

36.5

N48.4

ICD-10 Finland

Impotence of organic origin

4.4

36.3

141

266

KEB00

NOMESCO Finland

Biopsy of prostate

11.2

35.1

A06AC01

ATC

ispaghula (psylla seeds); oral

1.9

34.7

590

2693

G47.3

ICD-10 Finland

Sleep apnoea

1.6

34.4

1212

6892

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.7

33.5

842

4363

G03BA03

ATC

testosterone; systemic, rectal, sublingual, transdermal

2.1

32.8

420

1717

UJF32

NOMESCO Finland

Coloscopy

1.7

32.7

739

3701

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

2.1

32.2

414

1694

U01

ICPC

Dysuria/painful urination

6.0

31.9

127

Z01.8

ICD-10 Finland

Other specified special examinations

1.7

31.9

713

3561

U13

ICPC

Bladder symptom/complaint other

8.7

31.6

ZXC96

NOMESCO Finland

Robot assisted procedure

3.5

31.3

157

372

N48.1

ICD-10 Finland

Balanoposthitis

4.2

31.0

124

241

R07.4

ICD-10 Finland

Chest pain, unspecified

1.6

30.0

910

4946

N03AX16

ATC

pregabalin; oral

1.7

29.8

797

4182

J01CA08

ATC

pivmecillinam; oral

3.5

28.4

140

328

N30.9

ICD-10 Finland

Cystitis, unspecified

5.8

28.1

119

A02BC01

ATC

omeprazole; systemic

1.6

27.6

784

4173

N43.0

ICD-10 Finland

Encysted hydrocele

86.7

27.0

N35.9

ICD-10 Finland

Urethral stricture, unspecified

6.8

26.9

N48.6

ICD-10 Finland

Induratio penis plastica

30.1

26.3

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.5

26.1

1012

5812

R06.0

ICD-10 Finland

Dyspnoea

1.7

26.1

653

3352

N31.2

ICD-10 Finland

Flaccid neuropathic bladder, not elsewhere classified

12.5

26.0

M54.5

ICD-10 Finland

Low back pain

1.5

25.9

1109

6514

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

2.0

25.8

348

1447

N06AX21

ATC

duloxetine; oral

2.0

25.8

354

1482

N02AX02

ATC

tramadol; systemic, rectal

1.4

25.3

1591

10112

N03AX12

ATC

gabapentin; oral

1.8

25.1

511

2462

A02BC03

ATC

lansoprazole; oral

1.6

24.7

895

5052

KFD30

NOMESCO Finland

Operation for spermatocele

113.7

24.3

J01CA04

ATC

amoxicillin; systemic

1.4

24.1

2821

20070

G04BD07

ATC

tolterodine; oral

4.2

24.1

187

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.4

23.9

1401

8756

J01DB01

ATC

cefalexin; oral

1.5

23.4

3061

22178

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.6

23.3

704

3792

SAA02

NOMESCO Finland

Basic examination of mouth

1.4

23.0

2225

15217

M01AE03

ATC

ketoprofen; systemic, rectal

1.4

22.2

1321

8249

N06AX11

ATC

mirtazapine; oral

1.5

22.1

1010

5981

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.5

22.0

1178

7201

U29

ICPC

Urinary symptom/complaint other

5.5

21.9

102

L03

ICPC

Low back symptom/complaint

1.6

21.8

611

3222

SPAT1033

SPAT

Irrigation or wax removal of outer auditory canal

1.8

21.7

444

2139

SPAT1153

SPAT

Removal of sutures

1.5

21.5

904

5252

Z03.1

ICD-10 Finland

Observation for suspected malignant neoplasm

5.0

21.1

117

K40.9

ICD-10 Finland

Unilateral or unspecified inguinal hernia, without obstruction or gangrene

1.6

20.9

569

2973

A02BA02

ATC

ranitidine; systemic

1.6

20.9

545

2816

KCW02

NOMESCO Finland

Lavation of bladder for coagulated blood

12.2

20.7

NK6AN

NOMESCO Finland

Total body bone isotope imaging

4.4

20.6

142

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.5

20.4

749

4215

M01AE02

ATC

naproxen; oral, rectal

1.4

20.2

1951

13203

KCE02

NOMESCO Finland

Transluminal endoscopic extraction of calculus from bladder

15.0

20.2

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.1

20.2

246

982

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.7

20.1

482

2431

N06AA09

ATC

amitriptyline; systemic

2.0

19.9

261

1073

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.4

19.8

1744

11607

WX704

NOMESCO Finland

Intubation

2.1

19.7

250

1012

N31.9

ICD-10 Finland

Neuromuscular dysfunction of bladder, unspecified

7.3

19.6

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

1.9

19.5

305

1341

J01MA01

ATC

ofloxacin; systemic

2.0

19.4

255

1050

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.5

19.2

828

4818

M03BX02

ATC

tizanidine; oral

1.4

19.1

2483

17568

SPAT1301

SPAT

No procedures

1.5

19.1

748

4264

C05AA08

ATC

fluocortolone; rectal, topical

1.7

19.0

484

2480

M79.6

ICD-10 Finland

Pain in limb

1.4

19.0

991

5998

J01MA06

ATC

norfloxacin; oral

2.0

19.0

257

1069

M01AH05

ATC

etoricoxib; oral

1.4

18.9

2384

16766

Z01.2

ICD-10 Finland

Dental examination

1.4

18.9

1299

8267

J01AA02

ATC

doxycycline; systemic

1.4

18.8

2843

20595

R51.80

ICD-10 Finland

Headache

1.8

18.7

360

1697

WX402

NOMESCO Finland

General anaesthesia

1.6

18.6

600

3266

J02AC01

ATC

fluconazole; systemic

1.5

18.3

648

3606

P03

ICPC

Feeling depressed

2.1

18.2

218

862

SPAT1249

SPAT

Treatment-related counselling outside office

1.4

18.2

1015

6210

N30

ICD-10 Finland

Cystitis

4.4

18.2

126

D40.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Prostate

4.7

18.0

109

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.7

17.9

404

1998

SAA01

NOMESCO Finland

Simple examination of mouth

1.4

17.8

2595

18588

KDV12

NOMESCO Finland

Urethroscopic internal urethrotomy

6.8

17.7

SPAT1043

SPAT

Audiometry

2.2

17.7

180

664

N32.83

ICD-10 Finland

Nozzle synergy in the bladder neck

11.5

17.7

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.9

17.6

255

1090

H13

ICPC

Plugged feeling ear

1.7

17.5

424

2139

EB1SA

NOMESCO Finland

Dental X-ray, bite-wing X-ray on one side of the mouth

1.3

17.5

1698

11400

XX3DW

NOMESCO Finland

Time consuming IT work

1.9

17.4

287

1285

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.3

17.4

1755

11855

WZC30

NOMESCO Finland

Teaching

1.7

17.3

433

2206

6050A

ICD-9 Finland

Redundant prepuce and phimosis[PHIMOSIS]

+∞

17.2

KDE20

NOMESCO Finland

Removal of foreign body from urethra

5.0

17.2

R42

ICD-10 Finland

Dizziness and giddiness

1.6

17.2

456

2359

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.9

17.2

282

1262

R05

ICD-10 Finland

Cough

1.6

17.0

461

2399

8148/2-C61.9

ICD-O-3

Glandular intraepithelial neoplasia, high grade of prostate gland

21.1

17.0

R30.1

ICD-10 Finland

Vesical tenesmus

5.0

16.8

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.4

16.8

855

5130

R01AD09

ATC

mometasone; nasal

1.4

16.7

1397

9144

N41.8

ICD-10 Finland

Other inflammatory diseases of prostate

10.7

16.6

SPAT1240

SPAT

Therapeutic discussion

1.8

16.6

288

1312

N04BC05

ATC

pramipexole; oral

2.2

16.5

178

674

JN2CG

NOMESCO Finland

Extensive MRI examination of lower part of abdoment with high intensity magnet

3.9

16.5

143

N39.4

ICD-10 Finland

Other specified urinary incontinence

4.3

16.2

118

M75.4

ICD-10 Finland

Impingement syndrome of shoulder

1.8

16.1

271

1219

TPH04

NOMESCO Finland

Cathetrisation of vein

1.5

16.0

655

3757

N06AX16

ATC

venlafaxine; oral

1.6

15.9

420

2170

R06.5

ICD-10 Finland

Mouth breathing

1.6

15.9

447

2347

N21.0

ICD-10 Finland

Calculus in bladder

6.7

15.7

R01AD12

ATC

fluticasone furoate; nasal

1.4

15.6

890

5444

SFA10

NOMESCO Finland

Fillning on one surface of tooth

1.3

15.5

1858

12792

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.8

15.5

301

1424

G44.2

ICD-10 Finland

Tension-type headache

1.8

15.5

283

1311

C07AA05

ATC

propranolol; systemic

1.5

15.4

515

2821

N05CF01

ATC

zopiclone; oral

1.4

15.4

870

5312

7542

FHL

Circumcisio

40.5

15.3

SDA03

NOMESCO Finland

Demanding parodonthologic therapy

1.4

15.3

1217

7872

N05BA04

ATC

oxazepam; oral

1.5

15.3

610

3476

P01AB01

ATC

metronidazole; oral, rectal

1.4

15.2

1015

6375

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.5

15.2

700

4108

N06AB10

ATC

escitalopram; oral

1.5

15.2

578

3259

U70

ICPC

Pyelonephritis/pyelitis

8.1

14.8

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

1.9

14.8

232

1019

L17

ICPC

Foot/toe symptom/complaint

1.5

14.8

547

3063

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.7

14.8

355

1788

S18

ICPC

Laceration/cut

1.3

14.7

1217

7910

R05

ICPC

Cough

1.6

14.7

467

2528

M01AB05

ATC

diclofenac; systemic, rectal

1.3

14.7

2637

19160

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.3

14.6

1624

11030

L08

ICPC

Shoulder symptom/complaint

1.5

14.6

532

2970

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.4

14.5

904

5607

R02

ICPC

Shortness of breath/dyspnoea

1.8

14.5

246

1112

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.6

14.4

427

2271

I10

ICD-10 Finland

Essential (primary) hypertension

1.3

14.4

1838

12723

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.6

14.3

457

2472

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.3

14.3

1317

8691

PJD64

NOMESCO Finland

Laparoscopic dissection of iliac lymph nodes

3.3

14.3

184

SPAT1312

SPAT

General health counselling

1.4

14.2

737

4420

Y73

ICPC

Prostatitis/seminal vesiculitis

11.5

14.2

R01AD08

ATC

fluticasone; nasal

1.4

14.2

845

5200

AA1AD

NOMESCO Finland

CT of head and brain

1.4

14.1

655

3845

N05AH04

ATC

quetiapine; oral

1.5

14.0

531

2988

SPAT1325

SPAT

Vaccination

1.5

13.8

569

3259

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.5

13.8

489

2712

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

2.0

13.7

174

706

N41

ICD-10 Finland

Inflammatory diseases of prostate

4.4

13.7

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.6

13.7

382

1999

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.5

13.7

525

2962

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.4

13.6

646

3807

SAA03

NOMESCO Finland

Extended examination of mouth

1.3

13.5

1224

8040

WX290

NOMESCO Finland

Other blockade of nerve

1.3

13.4

1665

11437

SDA02

NOMESCO Finland

Parodonthologic therapy

1.4

13.4

940

5932

K59.09

ICD-10 Finland

Constipation, unspecified

2.5

13.4

110

364

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

1.7

13.4

263

1249

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.3

13.4

1196

7842

L01

ICPC

Neck symptom/complaint

1.7

13.3

283

1376

SPAT1097

SPAT

Recording of ECG

1.6

13.3

349

1798

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.5

13.3

581

3367

U06

ICPC

Haematuria

3.8

13.2

123

TKD00

NOMESCO Finland

Dilatation of urethra

10.5

13.1

JN3AD

NOMESCO Finland

Abdominal CT examination

1.8

13.1

245

1142

R23.8

ICD-10 Finland

Other and unspecified skin changes

1.6

13.1

321

1625

R13

ICD-10 Finland

Dysphagia

2.1

13.1

154

607

SPAT1310

SPAT

Counselling related to known health issue

1.4

13.1

756

4620

K30

ICD-10 Finland

Functional dyspepsia

1.8

13.0

234

1081

N02AJ06

ATC

codeine and paracetamol; systemic

1.3

13.0

1401

9425

KH1AD

NOMESCO Finland

CT of urinary organs

2.2

13.0

140

532

D01

ICPC

Abdominal pain/cramps general

1.9

13.0

202

887

R06AE07

ATC

cetirizine; oral

1.3

12.8

1156

7581

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.5

12.8

543

3126

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.6

12.8

358

1877

M01AE01

ATC

ibuprofen; systemic, rectal

1.4

12.7

3563

27317

U71

ICPC

Cystitis/urinary infection other

5.5

12.7

D06

ICPC

Abdominal pain localized other

2.1

12.7

142

547

R07.3

ICD-10 Finland

Other chest pain

1.7

12.7

257

1232

KE1AE

NOMESCO Finland

Percutaneous utlrasound examination fo prostata

9.1

12.7

R53

ICD-10 Finland

Malaise and fatigue

1.5

12.7

424

2320

KCV04

NOMESCO Finland

Distension of bladder with fluid

11.4

12.6

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.7

12.6

289

1436

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.0

12.6

172

721

N06AB04

ATC

citalopram; systemic

1.4

12.6

563

3276

N17

ICPC

Vertigo/dizziness

2.0

12.6

172

722

J01DA01

ATC

[U] cefalexin; systemic

1.3

12.6

2043

14493

A06AD11

ATC

lactulose; oral

1.7

12.6

272

1328

JAB30

NOMESCO Finland

Repair of inguinal hernia using prosthetic material

1.5

12.5

416

2271

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.7

12.5

283

1402

N43.2

ICD-10 Finland

Other hydrocele

43.2

12.5

L15

ICPC

Knee symptom/complaint

1.5

12.5

465

2606

WX110

NOMESCO Finland

Local anesthesy

1.3

12.4

2432

17655

H04.10

ICD-10 Finland

Dry eye syndrome

1.8

12.4

205

921

-1

NOMESCO Finland

1.3

12.3

1054

6849

G04BD04

ATC

oxybutynin; oral, transdermal

3.2

12.3

165

WX725

NOMESCO Finland

Noninvasive ventilation

2.0

12.3

153

619

N06AX12

ATC

bupropion; oral

1.8

12.2

211

962

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

1.8

12.2

230

1077

116

Kela drug reimbursment

Prostate cancer

2.4

12.2

103

349

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.7

12.1

258

1253

308

Kela drug reimbursment

Alprostadil, sildenafil and combination product containing aviptadil and phentolamine

3.1

12.1

178

A02BC04

ATC

rabeprazole; oral

1.7

12.1

246

1179

SPAT1262

SPAT

Handing over of treatment supplies

1.4

12.0

556

3255

N31.1

ICD-10 Finland

Reflex neuropathic bladder, not elsewhere classified

7.0

12.0

R52.9

ICD-10 Finland

Pain, unspecified

1.8

12.0

196

878

M17.1

ICD-10 Finland

Other primary gonarthrosis

1.4

11.9

546

3190

D29.1

ICD-10 Finland

Benign neoplasm: Prostate

9.2

11.9

KA1AE

NOMESCO Finland

Kidney ultrasound examination

2.7

11.8

243

KCH42

NOMESCO Finland

Transurethral incision or resection of bladder neck

32.4

11.8

M02AA07

ATC

piroxicam; topical

1.3

11.8

1090

7152

J01FF01

ATC

clindamycin; systemic

1.3

11.7

895

5710

M01AH01

ATC

celecoxib; oral (coxibs)

1.5

11.7

490

2814

N06AB06

ATC

sertraline; oral

1.6

11.7

297

1517

D07AB02

ATC

hydrocortisone butyrate; topical

1.4

11.7

727

4487

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

1.7

11.7

252

1231

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

2.0

11.6

154

639

M01AC06

ATC

meloxicam; systemic, rectal

1.3

11.6

1141

7553

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.8

11.6

219

1027

R00.2

ICD-10 Finland

Palpitations

2.0

11.5

141

567

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

2.0

11.5

155

646

R10.2

ICD-10 Finland

Pelvic and perineal pain

3.3

11.5

143

M25.5

ICD-10 Finland

Pain in joint

1.3

11.4

814

5133

KF8KT

NOMESCO Finland

Sclerotherapy of scrotum

56.7

11.4

SDA01

NOMESCO Finland

Simple parodonthologic therapy

1.4

11.4

643

3902

SDA04

NOMESCO Finland

Very demanding parodonthologic therapy

1.3

11.4

811

5115

N05BA01

ATC

diazepam; systemic, rectal

1.5

11.3

380

2080

J45.9

ICD-10 Finland

Asthma, unspecified

1.5

11.3

415

2314

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.8

11.3

206

954

A07AA02

ATC

nystatin; oral

2.2

11.2

115

429

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

2.0

11.2

146

601

B01AB05

ATC

enoxaparin; parenteral

1.3

11.2

788

4961

K03.64

ICD-10 Finland

Dental calculus supragingival

1.3

11.1

783

4928

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.8

11.1

192

878

SPAT1260

SPAT

Consultation of another employee

1.5

11.1

391

2165

WX002

NOMESCO Finland

Sedation and analgesia

1.4

11.1

510

2983

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.3

11.1

1717

12036

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.4

11.0

508

2967

R03AC02

ATC

salbutamol; inhalant

1.3

11.0

1532

10597

N50.8

ICD-10 Finland

Other specified disorders of male genital organs

8.5

10.9

D07AC01

ATC

betamethasone; topical

1.3

10.9

1018

6680

EB1AA

NOMESCO Finland

Tooth X-ray examination

1.3

10.9

2019

14448

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

2.8

10.8

200

Z01.9

ICD-10 Finland

Special examination, unspecified

2.0

10.8

139

571

N42.8

ICD-10 Finland

Other specified disorders of prostate

7.3

10.8

SFA20

NOMESCO Finland

Filling on two surfaces of tooth

1.3

10.7

2126

15319

H29

ICPC

Ear symptom/complaint other

1.8

10.7

192

889

M48.0

ICD-10 Finland

Spinal stenosis

1.6

10.7

279

1439

A03FA02

ATC

cisapride; oral, rectal

2.0

10.7

142

590

UKC05

NOMESCO Finland

Cystoscopy and bladder biopsy

4.7

10.6

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.5

10.6

363

1993

60798

ICD-8 Finland

Other disease of male genital organs, Alii definiti

+∞

10.5

H90.3

ICD-10 Finland

Sensorineural hearing loss, bilateral

1.5

10.5

324

1737

K02.1

ICD-10 Finland

Caries of dentine

1.2

10.5

2037

14625

SHB00

NOMESCO Finland

Prepation and fitting of bite rail to mouth

1.7

10.5

206

981

G04BD09

ATC

trospium; oral

4.5

10.4

Y05

ICPC

Scrotum/testis sympt/compl other

4.5

10.4

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.5

10.4

428

2447

A04

ICPC

Weakness/tiredness general

1.8

10.4

191

892

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

1.8

10.3

180

824

XF402

NOMESCO Finland

ECG with work load test

1.5

10.3

328

1772

R93.4

ICD-10 Finland

Abnormal findings on diagnostic imaging of urinary organs

6.4

10.3

SPAT1254

SPAT

Administration of medicine

1.6

10.3

292

1535

R01AD58

ATC

fluticasone, combinations; inhalant, nasal

1.4

10.3

590

3587

UJF30

NOMESCO Finland

Ileoscopy through colon

1.6

10.3

250

1264

C07AB02

ATC

metoprolol; systemic

1.5

10.3

370

2055

N45.0

ICD-10 Finland

Orchitis, epididymitis and epididymo-orchitis with abscess

18.5

10.3

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

2.7

10.2

215

M03BC01

ATC

orphenadrine (citrate); systemic

1.3

9.9

823

5300

M54.1

ICD-10 Finland

Radiculopathy

2.0

9.9

128

527

D11

ICPC

Diarrhoea

1.6

9.9

236

1187

N05CF02

ATC

zolpidem; oral

1.4

9.9

508

3030

R50.9

ICD-10 Finland

Fever, unspecified

1.5

9.8

359

1999

SPAT1104

SPAT

Monitoring of emergency patient

1.8

9.8

163

736

WX702

NOMESCO Finland

Supraglottic ventilation device

1.8

9.8

159

711

D41.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Kidney

2.5

9.8

253

Z71.8

ICD-10 Finland

Other specified counselling

1.4

9.7

588

3605

N12

ICD-10 Finland

Tubulo-interstitial nephritis, not specified as acute or chronic

4.5

9.7

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.5

9.7

303

1632

R05FB02

ATC

cough suppressants and expectorants

1.3

9.7

1007

6687

G04BE01

ATC

alprostadil; parenteral, urethral

3.0

9.7

153

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.6

9.7

262

1362

SPAT1168

SPAT

Catheterisation training

8.5

9.7

M43.1

ICD-10 Finland

Spondylolisthesis

2.1

9.6

111

437

SDE02

NOMESCO Finland

Periodontal treatment by dental hygienist

1.3

9.6

646

4026

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

2.1

9.6

104

399

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

1.6

9.5

231

1165

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

1.4

9.5

546

3318

Z00.0

ICD-10 Finland

General medical examination

1.4

9.4

436

2549

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.5

9.4

294

1583

R03DC03

ATC

montelukast; oral

1.5

9.4

379

2155

P20

ICPC

Memory disturbance

2.1

9.4

105

408

A03CA02

ATC

clidinium and psycholeptics; oral

2.0

9.4

118

481

N03AE01

ATC

clonazepam; systemic

1.8

9.4

166

765

KCV12

NOMESCO Finland

Urinary bladder endoscopic botulin therapy

9.6

9.4

D82

ICPC

Teeth/gum disease

1.3

9.3

1043

6984

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

1.7

9.3

180

853

N48.8

ICD-10 Finland

Other specified disorders of penis

7.4

9.3

M01AX05

ATC

glucosamine; oral

1.5

9.3

329

1821

JN4AD

NOMESCO Finland

Body CT examination

1.7

9.3

206

1015

JBC01

NOMESCO Finland

Laparoscopic gastro-oesophageal antireflux operation

2.5

9.3

234

H02AB06

ATC

prednisolone; systemic

1.2

9.2

1354

9368

KMAK

NOMESCO Finland

1.2

9.2

1776

12670

J01FA09

ATC

clarithromycin; systemic

1.3

9.2

974

6479

R96

ICPC

Asthma

1.8

9.1

155

705

N01

ICPC

Headache

1.8

9.1

151

682

N45

ICD-10 Finland

Orchitis and epididymitis

6.3

9.1

TKC10

NOMESCO Finland

Percutaneous puncture of bladder

6.3

9.1

R5140

NOMESCO Finland

Monitoring the use of the aid

1.4

9.1

471

2810

B02AA02

ATC

tranexamic acid; systemic

2.1

9.1

376

N05CD07

ATC

temazepam; oral

1.5

9.1

278

1489

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

1.6

9.1

212

1061

A01

ICPC

Pain general/multiple sites

1.8

9.1

145

647

R12

ICD-10 Finland

Heartburn

1.8

9.0

163

758

UDC00

NOMESCO Finland

Ear microscopy

1.7

9.0

190

924

TKF60

NOMESCO Finland

Puncture of scrotum

32.3

9.0

Y77

ICPC

Malignant neoplasm prostate

2.8

8.9

161

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

2.0

8.9

108

434

SHA01

NOMESCO Finland

Correction of physiology of bite - simple therapy visit

1.6

8.9

236

1221

M54.6

ICD-10 Finland

Pain in thoracic spine

1.7

8.9

178

853

K03.80

ICD-10 Finland

Irradiated enamel

2.0

8.9

114

467

S22

ICPC

Nail symptom/complaint

2.0

8.9

118

491

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

1.7

8.9

172

816

M23.2

ICD-10 Finland

Derangement of meniscus due to old tear or injury

1.4

8.9

465

2780

H02AB04

ATC

methylprednisolone; systemic

1.4

8.8

369

2115

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

1.6

8.8

208

1043

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.4

8.8

446

2649

KE3AT

NOMESCO Finland

Transrectal gold marker implantation in prostate under ultrasound guidance

3.0

8.8

140

J31.0

ICD-10 Finland

Chronic rhinitis

1.6

8.8

216

1097

D01BA02

ATC

terbinafine; oral; topical

1.3

8.8

994

6658

SCA01

NOMESCO Finland

Simple analysis and advice of nutrition with regard to dentistry

1.3

8.8

690

4400

G04BE03

ATC

sildenafil; oral

2.8

8.8

158

R32

ICD-10 Finland

Unspecified urinary incontinence

4.9

8.8

NBG15

NOMESCO Finland

Acromioplastia, arthroscopic

1.5

8.8

273

1469

UKD02

NOMESCO Finland

Urethroscopy

7.7

8.7

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.6

8.7

252

1333

N31.0

ICD-10 Finland

Uninhibited neuropathic bladder, not elsewhere classified

16.2

8.7

G04BE30

ATC

drugs used in erectile dysfunction - combinations

5.3

8.6

NE1CG

NOMESCO Finland

Pelvic, hip and femur extensive MRI examination with high intensity magnet

2.7

8.6

174

S29

ICPC

Skin symptom/complaint other

1.5

8.6

323

1811

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

2.2

8.6

314

A98

ICPC

Health maint/preventive medicine

1.4

8.6

3731

29132

L28

ICPC

Limited function/disability (L)

1.6

8.6

247

1305

E29.1

ICD-10 Finland

Testicular hypofunction

2.2

8.6

335

N05AA02

ATC

levomepromazine; systemic

1.7

8.5

162

764

TPH07

NOMESCO Finland

Cathetrisation of artery

1.5

8.5

285

1558

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

2.6

8.5

190

J01FA10

ATC

azithromycin; systemic

1.2

8.5

1845

13284

P06

ICPC

Sleep disturbance

1.5

8.5

260

1393

N50.9

ICD-10 Finland

Disorder of male genital organs, unspecified

6.4

8.5

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

1.7

8.5

180

877

D41.4

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Bladder

3.2

8.4

113

H02

ICPC

Hearing complaint

1.7

8.4

175

849

ABC36

NOMESCO Finland

Decompression of lumbar nerve roots

1.9

8.4

128

563

N03AG01

ATC

valproic acid; systemic, rectal

1.7

8.4

189

939

J05AB01

ATC

aciclovir; systemic

1.4

8.3

425

2528

P25

ICPC

Phase of life problem adult

2.3

8.3

265

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.6

8.3

211

1082

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.5

8.3

284

1562

E0000UV

ATC

1.3

8.3

965

6478

J34.2

ICD-10 Finland

Deviated nasal septum

1.5

8.3

285

1568

N41.3

ICD-10 Finland

Prostatocystitis

14.2

8.3

H81

ICPC

Excessive ear wax

1.4

8.3

364

2106

L04

ICPC

Chest symptom/complaint

1.9

8.3

117

499

M01AH02

ATC

rofecoxib; oral

1.5

8.2

299

1667

H03AA01

ATC

levothyroxine sodium; systemic

1.5

8.2

303

1692

R05FA02

ATC

opium derivatives and expectorants; systemic

1.3

8.2

1084

7387

F34.1

ICD-10 Finland

Dysthymia

2.1

8.2

381

VALMI

NOMESCO Finland

1.3

8.2

674

4323

R39.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the urinary system

4.1

8.2

JAP01

NOMESCO Finland

Laparoscopic freeing of adhesions in the peritoneal cavity

4.1

8.2

WZA90

NOMESCO Finland

Other doctors statement

1.3

8.2

658

4208

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.4

8.2

412

2447

JFA15

NOMESCO Finland

Endoscopic polypectomy in colon

1.9

8.1

122

532

JKA21

NOMESCO Finland

Laparoscopic cholecystectomy

1.6

8.1

201

1024

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

1.6

8.1

196

994

L82

ICD-10 Finland

Seborrhoeic keratosis

1.5

8.1

318

1803

M54.4

ICD-10 Finland

Lumbago with sciatica

1.4

8.1

488

2987

U04

ICPC

Incontinence urine

3.0

8.1

125

SPAT1255

SPAT

Intravenous administration of medicine

1.7

8.0

176

867

SPAT1028

SPAT

Ultrasound examination of paranasal sinuses

2.0

8.0

103

424

M79.1

ICD-10 Finland

Myalgia

1.5

8.0

273

1501

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.4

8.0

452

2740

R09

ICPC

Sinus symptom/complaint

1.9

8.0

115

497

H02.3

ICD-10 Finland

Blepharochalasis

2.1

7.9

344

SPAT1211

SPAT

Application of soft bandage

1.7

7.9

175

865

J02AC02

ATC

itraconazole; systemic

1.4

7.9

459

2791

K59.1

ICD-10 Finland

Functional diarrhoea

2.1

7.9

366

M01AX17

ATC

nimesulide; oral

1.3

7.9

679

4383

U99

ICPC

Urinary disease other

6.1

7.9

L02

ICPC

Back symptom/complaint

1.7

7.9

179

890

H01BA02

ATC

desmopressin; nasal, systemic, sublingual

3.6

7.9

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

1.9

7.9

106

446

N06AX26

ATC

vortioxetine; oral

1.7

7.8

154

736

J01DA09

ATC

[U] cefadroxil; inhalant, oral

1.3

7.8

792

5223

K42.9

ICD-10 Finland

Umbilical hernia without obstruction or gangrene

1.5

7.7

241

1298

N99.1

ICD-10 Finland

Postprocedural urethral stricture

8.1

7.7

XZZ00

NOMESCO Finland

Active surveillance of a diagnosed cancer

3.2

7.7

103

ZXA10

NOMESCO Finland

Bilateral

1.4

7.7

366

2152

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.4

7.7

387

2297

H93.1

ICD-10 Finland

Tinnitus

1.6

7.7

198

1021

QBE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin of trunk

1.6

7.7

177

884

C02AC05

ATC

moxonidine; oral

1.8

7.7

131

598

60100

ICD-8 Finland

Prostatitis, Acuta

+∞

7.7

L02AE02

ATC

leuprorelin; implant, parenteral

2.5

7.6

193

M01AC01

ATC

piroxicam; systemic, rectal

1.4

7.6

394

2351

F29

ICPC

Eye symptom/complaint other

1.7

7.6

153

735

C64.88

ICD-10 Finland

Other malignant neoplasm of kidney, except renal pelvis

2.4

7.6

216

N49.2

ICD-10 Finland

Inflammatory disorders of scrotum

8.6

7.6

AEA00

NOMESCO Finland

Replacement of impulse generator of stimulation device in the nervous system

4.5

7.6

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.5

7.6

230

1234

XA800

NOMESCO Finland

Neuropsychological investigation

1.7

7.5

166

818

R22.9

ICD-10 Finland

Localized swelling, mass and lump, unspecified

1.7

7.5

146

697

N30.1

ICD-10 Finland

Interstitial cystitis (chronic)

7.6

7.5

A28

ICPC

Limited function/disability NOS

1.6

7.5

194

999

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)

1.3

7.4

671

4358

UJG02

NOMESCO Finland

Proctoscopy

2.4

7.4

207

N06AG02

ATC

moclobemide; oral

1.8

7.4

129

593

N31.8

ICD-10 Finland

Other neuromuscular dysfunction of bladder

9.3

7.4

SPAT1377

SPAT

Polysomnography

1.8

7.4

116

516

UDQ12

NOMESCO Finland

Flexible laryngoscopy

1.7

7.4

158

773

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

1.9

7.4

112

492

A11

ICPC

Chest pain NOS

1.7

7.4

163

806

ZXA05

NOMESCO Finland

Left side

1.3

7.4

653

4231

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

1.9

7.4

102

434

R21

ICPC

Throat symptom/complaint

1.4

7.3

330

1921

NAG62

NOMESCO Finland

Posterior fusion of lumbar spine with fixation, 2-3 vertebraea

2.5

7.3

188

SPAT1161

SPAT

Ultrasound examination of urinary bladder

8.1

7.3

205

Kela drug reimbursment

Chronic hypertension

1.3

7.3

642

4157

WX240

NOMESCO Finland

Penis blockade

26.9

7.3

K40.2

ICD-10 Finland

Bilateral inguinal hernia, without obstruction or gangrene

2.0

7.2

397

M03BC51

ATC

orphenadrine, combinations; systemic

1.2

7.2

907

6134

R52.2

ICD-10 Finland

Other chronic pain

2.1

7.2

323

M70.6

ICD-10 Finland

Trochanteric bursitis

1.8

7.2

129

599

J01AA04

ATC

lymecycline; systemic

1.4

7.2

320

1857

K10.3

ICD-10 Finland

Alveolitis of jaws

1.7

7.2

134

630

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.8

7.2

125

574

SPAT1138

SPAT

Guidance concerning bowel function

4.4

7.2

SFA00

NOMESCO Finland

Small filling

1.4

7.1

388

2332

L90.0

ICD-10 Finland

Lichen sclerosus et atrophicus

4.1

7.1

KFD16

NOMESCO Finland

Partial excision of epididymis

17.8

7.1

D12.8

ICD-10 Finland

Benign neoplasm: Rectum

2.0

7.1

382

C10AA01

ATC

simvastatin; oral

1.2

7.1

1188

8285

C07AB07

ATC

bisoprolol; oral

1.2

7.1

1277

8974

D12

ICPC

Constipation

2.7

7.1

143

Z12.5

ICD-10 Finland

Special screening examination for neoplasm of prostate

3.4

7.1

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

1.7

7.0

138

660

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

1.8

7.0

113

509

F51.0

ICD-10 Finland

Nonorganic insomnia

1.4

7.0

300

1730

S04

ICPC

Lump/swelling localized

1.6

7.0

169

857

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

1.8

7.0

111

497

SPAT1216

SPAT

Assessment of functional ability

1.5

7.0

222

1203

H60.9

ICD-10 Finland

Otitis externa, unspecified

1.6

7.0

178

915

M02AA10

ATC

ketoprofen; topical

1.4

7.0

423

2592

TKC50

NOMESCO Finland

Training of urinary bladder

36.3

7.0

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

1.7

6.9

145

706

SFC01

NOMESCO Finland

Adjuvant procedure of filling therapy

1.2

6.9

960

6564

N02AA05

ATC

oxycodone; systemic

1.4

6.9

313

1824

J01FA06

ATC

roxithromycin; oral

1.2

6.9

1166

8140

R07.0

ICD-10 Finland

Pain in throat

1.8

6.9

117

537

M03BX01

ATC

baclofen; systemic

2.5

6.8

165

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

1.8

6.8

104

461

J05AB11

ATC

valaciclovir; oral

1.5

6.8

267

1514

F41.09

ICD-10 Finland

UNS Panic Syndrome

2.3

6.8

221

D17.1

ICD-10 Finland

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

1.9

6.8

402

D23.5

ICD-10 Finland

Benign neoplasm: Skin of trunk

2.4

6.8

181

R29

ICPC

Respiratory symptom/complaint other

1.7

6.8

139

675

J01AA07

ATC

tetracycline; systemic

1.4

6.8

318

1865

K61.1

ICD-10 Finland

Rectal abscess

4.7

6.8

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.4

6.7

315

1845

KAS10

NOMESCO Finland

Allogenic transplantation of kidney from cadaver donor

2.7

6.7

127

XKG00

NOMESCO Finland

Artificial induction of erection

8.7

6.7

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.5

6.7

204

1095

KGH96

NOMESCO Finland

Other reconstructive operation on penis

+∞

6.7

Z94.0

ICD-10 Finland

Kidney transplant status

2.5

6.7

162

DJD20

NOMESCO Finland

Plastic repair of septum of nose

1.5

6.7

208

1122

N13.3

ICD-10 Finland

Other and unspecified hydronephrosis

2.7

6.7

134

N05BA12

ATC

alprazolam; oral

1.5

6.6

262

1487

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

1.5

6.6

191

1011

L13

ICPC

Hip symptom/complaint

1.5

6.6

219

1197

N06AX03

ATC

mianserin; oral

1.7

6.6

122

574

F45.8

ICD-10 Finland

Other somatoform disorders

1.7

6.6

122

574

SPAT1305

SPAT

Counselling and guidance related to physical exercise

1.6

6.6

171

885

M77.1

ICD-10 Finland

Lateral epicondylitis

1.4

6.6

271

1553

M54.3

ICD-10 Finland

Sciatica

1.6

6.6

161

820

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

1.6

6.5

145

720

Y83.9

ICD-10 Finland

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.1

6.5

288

A06AC51

ATC

ispaghula, combinations; systemic

1.9

6.5

409

SPAT1307

SPAT

Psychosocial counselling and guidance

1.8

6.5

101

448

JAB11

NOMESCO Finland

Laparoscopic repair of inguinal hernia

1.9

6.5

379

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.4

6.5

261

1489

L04AD01

ATC

ciclosporin; systemic

2.1

6.4

273

A01AB09

ATC

miconazole; local oral

1.7

6.4

142

703

H43.8

ICD-10 Finland

Other disorders of vitreous body

1.6

6.4

144

718

I86.1

ICD-10 Finland

Scrotal varices

2.8

6.4

121

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

2.0

6.4

316

WX720

NOMESCO Finland

Own respiration

1.7

6.4

120

567

SFA30

NOMESCO Finland

Filling on tree or more surfaces of tooth

1.2

6.4

1578

11395

XG470

NOMESCO Finland

Measurement of diffusion capastity of the lungs

2.0

6.4

330

KC1AE

NOMESCO Finland

Percutaneous ultrasound examination of urinary bladder

16.2

6.3

TAB00

NOMESCO Finland

Lumbar puncture

1.7

6.3

121

576

S09

ICPC

Infected finger/toe

2.1

6.3

259

M47.9

ICD-10 Finland

Spondylosis, unspecified

1.9

6.3

355

E66.8

ICD-10 Finland

Other obesity

1.7

6.3

136

671

L04AA06

ATC

mycophenolic acid; systemic

2.0

6.3

292

KD1GB

NOMESCO Finland

Uretrocystogpaphy with X-ray

4.8

6.3

A02BD07

ATC

lansoprazole, amoxicillin and clarithromycin; systemic

1.7

6.3

117

552

SPAT1229

SPAT

Assessment of need for aid

1.7

6.3

115

539

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

1.4

6.3

268

1545

S82

ICPC

Naevus/mole

1.5

6.3

196

1061

JHB30

NOMESCO Finland

Rubber band ligature of haemorrhoids or prolapse of mucosa

1.6

6.3

158

812

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

1.5

6.3

190

1021

N86

ICPC

Multiple sclerosis

5.7

6.2

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

1.5

6.2

197

1067

R03BA05

ATC

fluticasone; inhalant

1.3

6.2

401

2479

KH1AE

SPAT

2.3

6.2

184

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

1.5

6.2

179

949

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.5

6.2

194

1049

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.4

6.2

266

1534

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.4

6.2

309

1833

SPAT1058

SPAT

PEF monitoring instruction

1.6

6.2

151

769

R55

ICD-10 Finland

Syncope and collapse

1.5

6.2

217

1204

N04BA03

ATC

levodopa, decarboxylase inhibitor and COMT inhibitor; oral

4.0

6.2

NF1AA

NOMESCO Finland

Hip X-ray examination

1.6

6.2

149

757

L90

ICPC

Osteoarthrosis of knee

1.8

6.1

107

495

N06AA12

ATC

doxepin; systemic

1.7

6.1

124

601

SPAT1170

SPAT

Uroflowmetry

32.3

6.1

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.4

6.1

259

1493

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

1.5

6.1

214

1186

F60.3

ICD-10 Finland

Emotionally unstable personality disorder

3.5

6.1

R01BA52

ATC

pseudoephedrine, combinations; oral

1.2

6.1

900

6184

J01.9

ICD-10 Finland

Acute sinusitis, unspecified

2.2

6.1

215

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.4

6.1

287

1689

C08CA02

ATC

felodipine; oral

1.6

6.1

168

883

H10.3

ICD-10 Finland

Acute conjunctivitis, unspecified

1.6

6.1

132

654

L05

ICPC

Flank/axilla symptom/complaint

1.7

6.1

115

547

M15.9

ICD-10 Finland

Polyarthrosis, unspecified

2.0

6.0

286

K59.0

ICD-10 Finland

Constipation

2.0

6.0

286

R11

ICD-10 Finland

Nausea and vomiting

1.7

6.0

123

596

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.5

6.0

187

1009

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.4

6.0

262

1518

A05

ICPC

Feeling ill

1.8

6.0

402

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

9070

36249

1.82

313.83

4.6

4.1

—

(40768800) Prostate Pathology biopsy report

1615

3121

3.13

310.98

1.2

—

(3030467) Casts [#/volume] in Urine by Automated count

6629

22499

2.04

307.65

4.0

3.1

e6/l

0.3

0.5

8.94

5278

16846

(3000850) Epithelial cells [#/volume] in Urine

5413

16662

2.19

307.65

3.0

2.6

e6/l

2.4

3.0

6.89

4805

14601

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

15693

61900

3.55

307.65

6.5

4.2

ug/l

3.9

3.2

1.29

14647

54974

(3035350) Ketones [Presence] in Urine by Test strip

9351

34766

2.05

307.65

4.2

3.0

estimate

0.0

0.99

1940

6210

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

10010

34353

2.40

307.65

3.9

2.6

ug/l

0.8

4.35

7990

21451

(3009261) Glucose [Presence] in Urine by Test strip

9396

35141

2.04

307.65

4.2

3.0

estimate

0.0

0.03

1882

5917

(3002582) Erythrocytes [#/volume] in Urine

7481

24480

2.22

307.65

4.1

3.1

e6/l

110.3

112.4

0.03

6143

18817

(3018095) Leukocytes [#/volume] in Urine

8044

27088

2.20

307.65

4.7

3.5

e6/l

107.8

82.1

1.13

6444

19953

(3031040) Bacteria [#/volume] in Urine by Automated count

13393

45170

3.33

307.65

5.4

3.4

e6/l

148.2

765.3

1.88

277

775

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

7412

27142

1.91

307.65

4.5

3.1

—

(3049717) Cytology report of Urine Cyto stain

1900

3366

3.47

307.65

2.6

3.1

—

(36304419) Bacteria [Presence] in Urine

6317

21490

2.01

307.65

3.9

3.0

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

13406

48329

2.97

307.65

5.7

3.6

20.5

22.7

63.43

8612

21188

(3026782) Osmolality of Urine

5012

15509

2.14

307.65

3.3

2.6

mosm/kgh2o

595.8

588.7

1.32

4334

13291

(3015736) pH of Urine

7380

26884

1.92

307.65

3.8

2.8

5.7

0.04

(3037467) Urinalysis macro (dipstick) panel - Urine

13343

49773

2.77

307.65

5.0

3.5

—

(3026008) Bacteria identified in Urine by Culture

6438

14572

3.30

307.65

3.4

2.6

—

(3021601) Nitrite [Presence] in Urine by Test strip

9266

34677

2.02

307.65

5.5

4.0

estimate

0.0

0.50

1976

6472

(3041096) Erythrocytes [Presence] in Urine by Automated

5335

18161

1.94

300.37

3.8

2.7

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

1877

4140

2.76

287.60

3.3

2.7

e6/l

0.2

0.4

4.31

1849

4073

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

13357

61342

1.81

272.35

8.2

8.1

u/l

78.5

81.1

5.01

12657

57937

(40768804) Tissue Pathology biopsy report

7071

27055

1.78

269.87

2.2

2.1

—

(3002256) Pathology report gross observation

3019

8773

2.14

255.18

1.4

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

4016

13004

1.97

254.50

3.9

2.9

e6/l

0.7

0.02

2504

7047

(3013826) Glucose [Moles/volume] in Serum or Plasma

11220

49947

1.69

237.42

5.5

mmol/l

6.9

7.0

8.24

10644

47273

(3029937) Albumin [Presence] in Urine by Test strip

5309

19269

1.79

234.07

4.6

3.3

estimate

0.0

1.75

1835

5765

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

4150

13940

1.89

233.58

3.6

2.7

e6/l

0.8

1.0

4.36

2629

7940

(3013707) Erythrocyte sedimentation rate by Westergren method

12129

55424

1.68

228.10

4.2

3.8

mm/h

11.8

12.9

10.42

11116

51241

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

15844

78347

1.92

224.70

19.1

15.9

mg/l

28.2

29.2

2.55

13409

63459

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

9083

38943

1.63

211.79

7.9

7.8

mmol/l

1.2

11.53

7629

33044

(3019550) Sodium [Moles/volume] in Serum or Plasma

16559

83822

1.98

202.32

22.7

18.6

mmol/l

139.7

139.6

4.90

16237

81791

(3023103) Potassium [Moles/volume] in Serum or Plasma

16583

84101

1.97

198.59

22.9

18.8

mmol/l

4.0

0.10

16240

81965

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

13747

66177

1.67

192.21

4.1

3.6

mu/l

2.1

2.3

0.44

12209

59652

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

7849

33150

1.60

186.10

4.4

3.7

ng/l

58.6

85.0

1.50

6190

25277

(3023368) Bacteria identified in Blood by Culture

6374

25691

1.62

181.76

4.6

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

8276

35618

1.58

178.89

6.9

7.2

mmol/l

1.2

8.52

7492

32625

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

10825

49687

1.56

175.33

3.2

3.0

pmol/l

15.0

14.9

7.64

9537

44621

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

9484

42245

1.56

175.19

6.4

7.1

umol/l

12.6

13.4

4.54

9051

40331

(3032080) INR in Blood by Coagulation assay

8685

37952

1.56

174.07

11.0

10.5

inr

1.3

1.4

0.58

2513

10230

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

6160

24874

1.61

172.06

2.8

u/l

58.9

59.9

0.57

5716

23147

(3013512) EKG study

6010

24165

1.61

170.43

4.7

4.0

—

(3044640) Blood type and Crossmatch panel - Blood

6113

24798

1.60

166.17

2.6

2.7

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

15430

77602

1.71

165.04

5.4

4.8

mmol/l

6.1

6.2

5.21

13886

70875

(40761511) CBC panel - Blood by Automated count

16042

81613

1.77

163.84

19.0

14.6

—

(3019150) Specific gravity of Urine by Refractometry

4158

15333

1.70

163.38

4.6

3.3

kg/l

1.0

0.52

682

2127

(40761535) Cells panel - Urine sediment

2048

6234

1.98

147.17

3.7

3.1

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

14991

75541

1.62

145.12

6.9

6.3

mmol/mol

40.8

41.1

2.35

13673

70097

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

6273

26346

1.53

140.89

3.2

3.1

ng/l

1767.7

1662.1

0.73

5388

22999

(3007461) Platelets [#/volume] in Blood

16811

87834

1.79

132.55

28.2

22.6

e9/l

228.0

232.1

13.93

16438

85145

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

16406

85134

1.72

132.24

11.9

10.7

u/l

28.0

29.9

5.12

15757

82167

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

7433

32673

1.49

132.22

2.1

2.0

pmol/l

93.5

90.8

5.06

4301

19030

(3035941) MCH [Entitic mass]

16813

87863

1.79

132.11

28.1

22.5

30.6

30.7

14.19

16576

86393

(3010813) Leukocytes [#/volume] in Blood

16818

87900

1.79

132.02

28.2

22.6

e9/l

6.9

7.0

0.53

16377

84871

(3026361) Erythrocytes [#/volume] in Blood

16815

87892

1.78

131.68

28.2

22.6

e12/l

4.6

9.61

16384

84825

(3024731) MCV [Entitic volume]

16813

87893

1.78

131.27

28.1

22.5

91.4

91.7

9.07

16576

86413

(3000963) Hemoglobin [Mass/volume] in Blood

16815

87916

1.78

131.00

28.4

22.7

g/l

138.1

139.6

26.36

16576

86433

(3024561) Albumin [Mass/volume] in Serum or Plasma

7949

35483

1.48

130.44

5.4

5.5

g/l

34.9

34.7

1.98

7372

33153

(3011397) Hemoglobin [Presence] in Urine by Test strip

4237

16680

1.58

123.35

4.1

3.0

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

6404

27700

1.48

120.03

3.0

2.8

ug/l

190.6

213.5

4.29

5781

25512

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

5923

25280

1.49

118.10

2.2

2.1

nmol/l

77.0

74.3

9.77

5211

22540

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

14831

75705

1.53

115.69

18.1

14.9

ml/min/173m2

75.4

78.6

69.00

12751

63052

(3015377) Calcium [Moles/volume] in Serum or Plasma

5631

24000

1.48

111.59

3.4

3.8

mmol/l

2.3

2.38

4833

21071

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

15635

80945

1.57

111.26

5.7

5.2

mmol/l

2.5

2.6

24.28

14211

74924

(3021960) Folate [Moles/volume] in Serum or Plasma

4497

18298

1.53

111.21

1.6

nmol/l

18.7

18.9

0.38

3821

15989

(3019225) pH of Specimen

2095

7126

1.76

104.80

4.9

4.5

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

9426

44608

1.41

103.75

8.9

9.5

e9/l

4.4

0.27

8257

38638

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

2569

9323

1.66

101.57

4.9

4.6

31.4

30.8

2.29

1764

6517

(3013115) Eosinophils [#/volume] in Blood

8602

40195

1.40

100.67

6.0

6.2

e9/l

0.2

0.22

7483

35001

(3019309) Folate [Moles/volume] in Red Blood Cells

3816

15267

1.53

100.36

1.8

nmol/l

1133.0

1140.7

0.19

2872

11734

(3019069) Monocytes/100 leukocytes in Blood

7942

36625

1.41

100.08

6.5

9.1

9.2

0.90

7370

34452

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

4726

19800

1.48

99.70

2.3

2.2

mg/l

3.0

1.02

3986

16843

(3006504) Eosinophils/100 leukocytes in Blood

7899

36434

1.40

99.08

6.2

6.3

2.9

0.22

7306

34166

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

15284

79267

1.51

98.57

5.1

4.7

mmol/l

4.3

4.4

29.92

13976

73778

(3002030) Lymphocytes/100 leukocytes in Blood

8078

37465

1.40

97.66

6.4

6.3

25.7

25.9

0.95

7438

35018

(3017446) Testosterone [Moles/volume] in Serum or Plasma

3034

11602

1.58

96.84

2.3

2.2

nmol/l

13.1

13.0

0.30

2682

10332

(42870588) Differential panel, method unspecified - Blood

6119

27067

1.43

96.45

5.8

6.2

—

(3018010) Neutrophils/100 leukocytes in Blood

7950

36844

1.40

95.94

6.1

58.8

58.5

0.99

7352

34647

(3006315) Basophils [#/volume] in Blood

8347

39124

1.39

93.24

5.8

6.0

e9/l

0.0

7.89

7213

33555

(3022096) Basophils/100 leukocytes in Blood

7669

35451

1.39

92.96

6.2

6.3

0.6

0.7

2.42

7100

33288

(40761536) Microorganisms panel - Urine sediment

1766

5916

1.77

92.36

4.7

3.3

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

15139

78645

1.48

92.22

5.1

4.6

mmol/l

1.3

0.10

13747

72685

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

4617

19526

1.46

91.43

2.6

—

(3001604) Monocytes [#/volume] in Blood

8283

38891

1.38

90.63

5.8

6.0

e9/l

0.6

0.7

2.41

7148

33308

(3019198) Lymphocytes [#/volume] in Blood

8473

39953

1.38

90.15

5.9

6.0

e9/l

1.8

1.9

1.96

7407

34870

(3022621) pH of Urine by Test strip

1394

4372

1.88

89.80

3.1

2.3

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

4033

16678

1.48

89.07

1.7

pmol/l

35779940.5

29672315.5

0.26

3284

13929

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

14701

76484

1.42

80.67

4.5

4.2

mmol/l

1.3

1.4

26.14

13272

70288

(3044889) 12 lead EKG panel

11808

59251

1.36

80.57

4.5

4.0

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

3454

14205

1.47

76.82

2.0

1.9

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

5787

26119

1.38

76.76

2.4

2.2

u/l

241.8

262.0

0.54

5427

24590

(3000330) Specific gravity of Urine by Test strip

1161

3667

1.86

72.74

4.2

3.0

—

(3045414) Leukocytes [Presence] in Urine

937

2806

1.95

68.67

2.0

1.7

—

(3018418) pH of Serum or Plasma

5089

22827

1.37

68.33

4.7

7.4

0.72

1061

4460

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

8148

39260

1.32

67.74

2.3

2.2

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

2758

11265

1.46

62.04

1.2

u/ml

2.1

2.2

0.04

674

3004

(3009542) Hematocrit [Volume Fraction] of Blood

13599

70857

1.33

61.21

19.6

16.9

40.1

40.6

5.25

8431

49509

(40768797) Stomach Pathology biopsy report

2468

9915

1.48

60.17

1.3

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

1651

6081

1.60

59.50

3.8

3.6

kpa

5.1

0.25

1516

5609

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

1581

5779

1.61

58.75

3.8

3.6

mmol/l

1.6

0.01

1138

4198

(3020682) Albumin/Creatinine [Ratio] in Urine

6445

30475

1.31

58.54

4.3

4.1

mg/mmol

8.9

9.7

0.62

4423

21022

(3009343) pH of Capillary blood

1626

6002

1.60

58.01

3.9

3.6

7.4

0.01

205

780

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

761

2285

1.94

55.21

1.7

1.5

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

811

2495

1.89

54.79

1.7

1.6

—

(3027945) Reticulocytes/100 erythrocytes in Blood

2618

10841

1.44

54.12

2.6

2.5

1.7

1.8

4.35

2319

9661

(3023520) Reticulocytes [#/volume] in Blood

2048

8082

1.50

54.06

2.6

2.7

e9/l

66.1

69.6

4.79

1615

6152

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

2194

8790

1.48

53.77

3.8

3.6

—

(3012516) Albumin [Mass/volume] in Urine

6099

28880

1.30

53.52

3.5

3.3

mg/l

445.0

331.0

1.06

4200

20075

(3009508) Creatinine [Moles/volume] in Urine

6178

29326

1.30

53.12

3.4

3.3

mmol/l

8.3

8.7

8.56

5111

24705

(3048689) Calprotectin [Mass/mass] in Stool

1639

6225

1.55

51.49

2.3

2.5

ug/g

164.4

176.7

0.54

1287

5086

(3037121) Protein [Mass/volume] in Urine

846

2704

1.82

50.75

3.2

3.4

g/l

0.3

0.39

370

1564

(3022145) Colonoscopy Study observation

2133

8616

1.46

49.91

1.4

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

1360

4992

1.60

49.37

5.0

4.7

ng/l

114.6

107.1

1.15

1183

4382

(1761482) Bacteria [#/volume] in Urine by Culture

688

2077

1.92

49.11

4.7

3.1

—

(3002385) Erythrocyte distribution width [Ratio]

12390

64497

1.27

48.64

22.8

19.1

13.8

0.71

12166

63033

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

10241

52343

1.25

45.14

3.5

3.3

u/l

56.8

63.9

9.00

9429

48796

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

4453

20587

1.31

44.96

1.7

mmol/l

1.4

6.49

3631

17108

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

1471

5634

1.53

44.23

1.6

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

1034

3646

1.65

43.92

4.1

4.0

mmol/l

24.7

24.6

0.13

941

3364

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

3557

15980

1.33

43.86

1.8

mg/l

1.4

1.5

0.77

2766

12725

(3022313) Gas panel - Capillary blood

1191

4371

1.59

43.10

4.0

3.8

—

(3022948) Iron [Moles/volume] in Serum or Plasma

3159

13980

1.35

42.99

2.8

2.7

umol/l

19.5

13.0

0.50

2898

13066

(3004588) Protein electrophoresis panel - Serum or Plasma

1582

6217

1.49

42.07

2.4

2.5

—

(3003694) ABO and Rh group [Type] in Blood

4643

21831

1.28

40.40

1.3

—

(3026493) Urate [Moles/volume] in Serum or Plasma

5322

25576

1.26

38.27

3.2

3.0

umol/l

4365.5

5089.3

0.58

4574

22408

(3007164) IgA [Mass/volume] in Serum or Plasma

2530

11029

1.36

37.47

1.5

g/l

2.7

3.0

9.15

1541

7053

(3020630) Protein [Mass/volume] in Serum or Plasma

1839

7648

1.41

36.10

2.6

g/l

65.9

66.6

3.74

1671

7055

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

950

3450

1.60

35.80

2.0

—

(3014051) Protein [Presence] in Urine by Test strip

468

1381

1.96

35.69

2.5

2.0

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

2936

13180

1.32

35.50

2.8

2.7

g/l

2.2

0.28

2706

12272

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

5424

26333

1.24

34.95

3.3

3.4

u/l

34.0

39.1

2.79

5130

24956

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

1043

3897

1.56

34.83

2.5

2.4

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

885

3180

1.62

34.81

1.8

—

(3017732) Neutrophils [#/volume] in Blood

1252

4870

1.50

34.77

3.0

3.1

e9/l

4.0

4.3

2.99

918

3735

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

2304

10019

1.35

34.44

1.9

1.7

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

3743

17426

1.28

34.30

4.2

3.9

ng/l

530.4

772.7

1.80

3178

14957

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

1036

3891

1.55

33.80

5.2

5.6

1.7

0.50

965

3673

(3007930) Methemoglobin/Hemoglobin.total in Blood

1015

3803

1.55

33.47

5.2

5.7

0.9

0.05

947

3585

(3000494) Fungus identified in Specimen by Culture

2149

9289

1.36

33.31

1.5

—

(3022217) INR in Platelet poor plasma by Coagulation assay

2918

13195

1.31

33.26

28.7

27.1

inr

1.5

0.79

406

1812

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

1296

5137

1.47

32.77

1.8

1.7

—

(4035726)

1625

6721

1.41

32.76

1.3

1.4

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

1552

6371

1.42

32.62

4.4

4.5

mmol/l

1.2

0.76

1373

5658

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

2293

10049

1.34

32.44

1.9

1.8

—

(3021589) Normoblasts [#/volume] in Blood

7023

35288

1.21

31.72

11.8

10.2

e9/l

0.0

1.09

5859

29013

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

2756

12478

1.30

30.91

2.9

2.8

23.3

0.03

2275

10776

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

652

2250

1.68

29.98

1.3

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

2551

11473

1.31

29.96

4.2

4.6

u/l

237.4

247.4

2.94

2413

10914

(4024509)

201

448

2.58

29.64

1.5

1.4

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

806

2947

1.58

29.50

1.9

pmol/l

203.9

200.1

0.53

764

2783

(3003458) Phosphate [Moles/volume] in Serum or Plasma

2710

12313

1.30

29.48

7.1

6.7

mmol/l

1.0

0.44

2536

11588

(3047181) Lactate [Moles/volume] in Blood

785

2863

1.59

29.03

5.9

7.1

mmol/l

1.4

0.16

684

2562

(3018677) aPTT in Platelet poor plasma by Coagulation assay

3224

15014

1.27

28.82

2.0

2.2

30.1

30.5

2.49

3131

14613

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

1256

5072

1.44

28.75

1.6

1.5

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

458

1452

1.82

28.23

1.4

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

2960

13672

1.28

28.21

3.1

3.6

mmol/l

2.4

3.34

2571

11916

(21494755) Public health laboratory ask at order entry panel

791

6735

0.66

27.65

1.5

1.4

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

953

3674

1.50

27.53

1.3

1.2

—

(3045424) Erythrocytes [Presence] in Urine

371

1113

1.92

27.08

1.5

1.3

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

310

877

2.03

26.65

2.1

mg/l

32.6

28.5

0.39

250

(3017181) Myelocytes/100 leukocytes in Blood

1628

7005

1.36

25.65

4.1

0.9

1.0

0.41

546

2282

(36660697) Celiac disease serology panel - Serum

1006

3979

1.47

25.61

1.2

1.1

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

1819

8005

1.33

24.62

3.0

ng/l

223.0

252.5

1.62

1659

7283

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

1040

4182

1.44

24.29

1.9

2.1

ug/l

1.9

2.2

0.46

916

3767

(3025159) Blasts/100 leukocytes in Blood

1437

6122

1.37

24.06

4.1

0.1

0.2

0.20

447

1751

(3021440) Promyelocytes/100 leukocytes in Blood

1536

6618

1.35

23.93

4.2

4.1

0.1

0.65

514

2116

(4010399)

1360

5758

1.37

23.66

1.5

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

1470

6302

1.36

23.65

7.1

8.2

mmol/l

24.5

24.4

0.51

1371

5929

(3027801) Oxygen [Partial pressure] in Arterial blood

2563

11879

1.27

23.35

7.1

8.5

kpa

11.8

12.0

1.47

2432

11351

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

2294

10488

1.28

23.35

8.5

7.8

—

(3003396) Base excess in Arterial blood by calculation

2559

11864

1.27

23.25

7.1

8.4

mmol/l

1.0

0.9

1.39

1957

9413

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

2562

11888

1.26

23.10

7.1

8.5

kpa

5.1

0.31

2433

11363

(3025941) Bacteria identified in Stool by Culture

896

3535

1.47

23.10

1.3

1.2

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

595

2152

1.60

22.82

1.4

1.5

ug/g

266.4

246.2

1.43

378

1309

(3016502) Oxygen saturation in Arterial blood

2350

10806

1.27

22.81

7.4

8.9

95.4

0.15

2253

10458

(3007853) Bacteria identified in Skin by Aerobe culture

2168

9908

1.28

22.06

1.8

1.9

—

(3002179) Metamyelocytes/100 leukocytes in Blood

1462

6332

1.34

21.97

3.9

0.8

0.6

0.66

402

1645

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

1000

4075

1.42

21.72

1.8

1.7

nmol/l

42.0

42.1

0.06

960

3953

(3003327) Ova and parasites identified in Stool by Light microscopy

486

1696

1.65

21.51

1.7

—

(3018572) Chloride [Moles/volume] in Blood

575

2102

1.58

21.11

6.7

8.1

mmol/l

105.5

105.0

1.30

513

1923

(3039000) Anion gap in Blood

575

2102

1.58

21.11

6.7

8.0

mmol/l

11.2

11.4

0.82

513

1923

(3042936) Bacteria identified in Isolate by Culture

2797

13257

1.24

20.74

2.1

2.2

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

3119

14960

1.23

20.67

3.5

3.9

mmol/l

0.8

1.99

2920

14108

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

1068

4443

1.39

20.61

2.3

2.4

au/ml

32.0

23.9

0.56

195

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

2058

9427

1.27

20.47

2.8

3.2

umol/l

9.3

11.6

3.17

1856

8508

(3019060) Gas panel - Arterial blood

1553

6855

1.32

20.45

4.9

5.4

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

280

844

1.91

20.28

1.4

1.5

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

1388

6036

1.34

20.26

2.4

2.7

nmol/l

363.9

370.6

0.45

1259

5669

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

279

843

1.90

20.07

1.4

1.5

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

279

844

1.90

20.00

1.4

1.5

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

287

880

1.87

19.76

1.4

1.5

—

(3020779) Urea [Moles/volume] in Serum or Plasma

2108

9747

1.26

19.35

8.2

7.9

mmol/l

11.3

10.6

2.93

2001

9280

(3024522) Salmonella sp identified in Specimen by Organism specific culture

280

861

1.87

19.13

1.4

1.5

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

964

3995

1.40

19.03

1.3

au/ml

66.7

52.9

0.65

191

(3006184) Hemoglobin [Mass/volume] in Capillary blood

566

2123

1.54

18.61

2.4

2.2

g/l

131.2

132.0

0.28

411

1507

(3002173) Hemoglobin [Mass/volume] in Arterial blood

2117

9836

1.26

18.61

7.9

9.5

g/l

123.5

123.3

0.12

2027

9552

(40760892) CBC W Ordered Manual Differential panel - Blood

3382

16515

1.20

18.45

5.0

4.6

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

277

860

1.85

18.40

1.4

1.5

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

2137

9960

1.25

18.26

1.3

1.2

iu/ml

35.0

44.8

1.26

606

3050

(40768443) Skin Pathology biopsy report

786

3169

1.43

18.11

1.2

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

660

2579

1.48

17.89

3.4

3.1

mmol/l

24.6

24.4

0.24

585

2240

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

1959

9089

1.26

17.37

1.3

1.2

u/ml

14.2

14.4

0.03

694

3437

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

594

2287

1.50

17.32

1.1

1.0

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

1540

6942

1.29

17.28

1.3

1.2

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

443

1599

1.59

17.23

1.1

1.2

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

1930

8948

1.26

17.22

4.2

4.5

ug/l

22.7

37.0

1.15

1614

7615

(3039443) Prostate specific Ag panel - Serum or Plasma

870

3610

1.39

17.06

1.9

1.6

—

(3044927) Protein electrophoresis panel - Urine

280

896

1.79

16.94

1.1

1.2

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

2676

12902

1.21

16.49

7.0

8.3

mmol/l

104.6

104.5

0.54

2611

12637

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

274

879

1.79

16.45

2.6

3.0

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

854

3555

1.39

16.43

2.5

2.4

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

854

3558

1.39

16.35

2.5

2.4

g/l

7.2

7.4

2.00

607

2703

(3027273) Bicarbonate [Moles/volume] in Venous blood

1102

4783

1.33

16.26

4.4

3.6

mmol/l

25.1

25.0

0.35

1057

4656

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

851

3549

1.38

16.20

2.5

2.4

g/l

3.8

4.0

2.05

583

2603

(3037522) Nuclear Ab [Titer] in Serum

1857

8645

1.25

15.93

1.3

titre

419.1

465.1

0.63

337

1613

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

529

2031

1.50

15.68

1.1

u/ml

2.0

18.7

—

(3002032) Base excess in Venous blood by calculation

1964

9230

1.24

15.46

4.5

4.1

mmol/l

1.7

0.03

1607

7469

(3021447) Carbon dioxide [Partial pressure] in Venous blood

1968

9253

1.24

15.42

4.5

4.1

kpa

5.8

0.65

1905

8995

(3012544) pH of Venous blood

2045

9657

1.23

15.39

4.5

4.1

7.4

0.17

(3028626) Oxygen [Partial pressure] in Capillary blood

560

2187

1.47

15.28

3.1

2.9

kpa

8.0

7.9

0.87

518

2016

(3009214) Lutropin [Units/volume] in Serum or Plasma

522

2014

1.49

15.12

1.4

u/l

6.5

6.3

0.29

414

1642

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

1680

7782

1.25

15.03

1.5

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

168

474

2.03

14.78

1.5

—

(3021901) Oxygen saturation in Capillary blood

495

1898

1.50

14.78

3.1

2.9

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

1274

5718

1.29

14.75

9.3

11.5

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

360

1287

1.61

14.63

1.1

u/ml

7.7

0.01

155

(3004119) Hemoglobin [Mass/volume] in Venous blood

1327

6009

1.28

14.33

4.1

3.4

g/l

130.4

130.1

0.13

1284

5887

(3033658) Prothrombin time (PT) actual/Normal

4378

22270

1.16

14.12

4.2

4.6

83.1

83.2

0.14

4283

21787

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

1008

4410

1.32

14.09

4.8

4.0

49.2

48.0

0.78

996

4357

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

788

3324

1.37

14.02

2.5

g/l

3.0

3.1

1.12

594

2661

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

163

466

2.00

13.88

1.5

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

181

538

1.93

13.83

2.6

2.4

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

840

3588

1.35

13.81

2.8

2.7

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

1047

4619

1.31

13.79

1.8

1.7

g/l

1.5

1.6

0.62

904

3946

(3005719) IgG [Mass/volume] in Serum or Plasma

1271

5776

1.27

13.33

2.7

2.6

g/l

10.4

11.1

4.86

1148

5304

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

466

1811

1.48

13.09

1.3

mg/l

570.6

605.6

0.72

440

1727

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

155

446

1.99

13.00

2.7

2.6

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

193

599

1.85

12.99

1.9

1.8

u/field

1.4

1.1

0.40

244

(3008037) Lactate [Moles/volume] in Venous blood

517

2059

1.44

12.82

3.9

3.1

mmol/l

1.5

1.7

5.02

504

2014

(3038515) Glucose [Moles/volume] in Venous blood

494

1956

1.45

12.64

4.0

3.2

mmol/l

7.5

8.0

3.77

482

1921

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

711

3003

1.36

12.58

3.5

3.4

ratio

2.4

6.0

0.91

229

(3026389) Candida sp identified in Specimen by Organism specific culture

206

660

1.79

12.55

1.4

1.3

—

(3004809) Band form neutrophils/100 leukocytes in Blood

406

1553

1.50

12.34

3.7

3.6

2.0

1.4

1.61

330

1172

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

142

404

2.01

12.31

1.8

1.6

u/field

2.5

2.2

0.25

102

296

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

776

3342

1.34

12.11

2.5

2.4

g/l

10.0

10.6

3.40

643

2855

(3024354) Oxygen [Partial pressure] in Venous blood

1583

7460

1.23

12.06

3.7

3.2

kpa

4.6

0.52

1523

7206

(40758558) Short blood count panel - Blood

3871

19711

1.15

12.02

6.4

7.4

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

725

3096

1.35

11.97

3.5

3.4

mg/l

41.8

48.5

0.61

593

2496

(3008757) Leukocyte morphology finding [Identifier] in Blood

278

986

1.62

11.77

4.2

4.1

—

(40767503) Oxygen content in Capillary blood by calculation

515

2085

1.42

11.73

2.7

2.6

16.5

0.05

288

1114

(3009445) Proteinase 3 Ab [Units/volume] in Serum

898

3968

1.31

11.72

1.8

1.5

u/ml

27.0

16.7

0.68

(3034860) Kappa light chains.free [Mass/volume] in Serum

722

3094

1.34

11.66

3.5

3.4

mg/l

69.4

60.4

0.44

584

2491

(3040151) Glucose [Moles/volume] in Capillary blood

292

1059

1.58

11.30

31.1

6.5

mmol/l

7.3

7.5

0.38

231

880

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

708

3048

1.34

11.11

2.4

2.7

g/l

1.0

1.2

0.46

607

2629

(3044290) Cell count panel - Cerebral spinal fluid

379

1466

1.48

10.97

1.3

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

366

1408

1.49

10.89

1.5

1.8

mu/l

252.0

259.6

0.18

344

1335

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

753

3281

1.32

10.88

1.8

1.9

u/l

36.8

38.1

0.81

652

2842

(3033705) Calcium.ionized [Moles/volume] in Venous blood

308

1147

1.54

10.66

2.8

2.4

—

(3005322) IgE [Units/volume] in Serum or Plasma

808

3566

1.31

10.66

1.4

1.3

u/ml

263.1

340.7

1.27

739

3322

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

656

2813

1.34

10.59

3.3

3.5

pmol/l

4.5

4.4

0.18

585

2540

(3037756) Immunofixation for Serum or Plasma

507

2093

1.39

10.38

1.6

1.7

—

(40760888) Immunoglobulin light chains.free panel - Serum

553

2325

1.37

10.15

3.5

3.4

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

291

1084

1.54

10.09

1.5

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

404

1613

1.44

9.99

1.3

1.2

mmol/l

3.9

0.13

372

1528

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

1497

7166

1.21

9.74

2.9

2.7

ml/min/173m2

61.7

64.7

2.07

618

2722

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

126

376

1.92

9.68

1.5

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

126

376

1.92

9.68

1.5

—

(3010421) pH of Blood

594

2547

1.34

9.62

4.7

7.4

0.13

507

2210

(3004616) Nuclear Ab [Presence] in Serum

212

743

1.63

9.51

1.2

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

433

1768

1.41

9.49

1.2

titre

366.7

65.1

1.02

(1616796) Gas panel - Central venous blood

543

2302

1.36

9.48

4.1

4.0

—

(3028271) Lactate [Moles/volume] in Capillary blood

377

1505

1.44

9.36

2.0

mmol/l

1.7

1.9

2.81

363

1466

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

392

1577

1.43

9.34

1.3

1.4

e6/l

19.0

31.4

0.36

302

1221

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

366

1462

1.44

9.07

5.9

6.4

mg/l

11.4

0.00

336

1353

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

391

1581

1.42

9.07

1.4

e6/l

678.3

2479.8

0.71

315

1293

(46235355) HIV 1 and 2 tests - Meaningful Use set

1825

8950

1.18

9.07

1.7

1.6

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

185

634

1.67

9.06

1.0

ng/l

39.8

40.8

0.12

132

425

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

185

635

1.67

9.01

1.0

ng/l

671.6

769.2

2.15

130

421

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

469

1959

1.37

9.01

6.3

iu/ml

1224.4

1871.3

0.29

334

(3028026) IgM [Mass/volume] in Serum or Plasma

983

4550

1.24

8.87

2.0

g/l

1.2

1.3

0.50

889

4135

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

507

2154

1.35

8.77

1.6

1.7

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

1844

9089

1.17

8.61

2.5

2.3

ug/l

7.3

9.4

4.02

1584

8182

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

183

635

1.65

8.58

1.0

ng/l

294.4

299.3

0.09

134

433

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

150

494

1.74

8.50

1.8

1.7

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

150

494

1.74

8.50

1.8

2.1

nmol/l

16.6

15.9

0.43

136

468

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

628

2768

1.30

8.44

2.2

2.4

g/l

37.6

37.3

0.65

539

2431

(3013727) Leukocytes other/100 leukocytes in Blood

101

294

1.96

8.39

4.0

3.8

58.7

53.6

1.40

288

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

684

3054

1.29

8.35

1.6

titre

127.2

261.1

1.63

106

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

218

2.12

8.27

1.2

1.3

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

430

1803

1.37

8.12

3.8

3.3

mg/l

31.7

30.9

0.13

276

1168

(3020650) Glucose [Presence] in Urine

168

2.28

8.08

1.5

1.2

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

579

2541

1.31

8.05

1.5

1.4

iu/ml

10.9

8.9

0.20

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

342

1381

1.42

8.05

1.2

u/ml

4.1

6.1

0.69

196

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

104

311

1.91

8.02

1.2

1.1

66.7

56.1

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

237

891

1.52

7.99

1.4

1.3

nmol/l

0.6

2.2

0.76

223

859

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

527

2287

1.32

7.95

1.7

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

338

1366

1.42

7.93

1.2

u/ml

9.3

9.0

0.02

136

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

404

1684

1.38

7.92

1.2

1.3

u/l

37.6

36.6

0.04

351

1475

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

354

1444

1.41

7.88

1.2

u/ml

50.2

42.4

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

949

6549

0.82

7.79

2.0

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

283

1110

1.46

7.79

1.5

63.5

64.2

0.10

186

711

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

265

1026

1.48

7.78

1.1

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

209

772

1.55

7.65

1.4

1.3

nmol/l

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

235

892

1.51

7.60

1.4

1.3

nmol/l

0.3

0.02

(3014271) Vancomycin [Susceptibility]

132

435

1.74

7.53

3.0

2.8

—

(3017704) Immunofixation for Urine

154

530

1.66

7.51

1.6

1.5

—

(3043410) Blood group antigens tested for on Red Blood Cells

212

2.08

7.47

1.7

1.8

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

610

2727

1.28

7.42

2.3

2.5

g/l

0.0

0.23

558

2492

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

441

1889

1.34

7.30

1.5

1.6

—

(3052851) Hemolysis interference index of Serum or Plasma

573

2548

1.29

7.27

3.3

3.7

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

582

2596

1.29

7.21

1.4

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

108

340

1.82

7.18

1.3

—

(3012501) Base excess in Blood by calculation

515

2262

1.31

7.17

4.7

4.8

mmol/l

2.4

2.5

0.61

358

1520

(3027315) Oxygen [Partial pressure] in Blood

517

2272

1.31

7.17

4.7

4.8

kpa

8.6

8.4

1.37

507

2217

(3015171) Extractable nuclear Ab [Units/volume] in Serum

475

2063

1.32

7.17

1.1

1.2

u/ml

0.8

0.6

0.16

190

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

297

1196

1.42

7.15

1.2

u/ml

1.6

7.2

1.56

(3013290) Carbon dioxide [Partial pressure] in Blood

515

2263

1.31

7.15

4.7

4.8

kpa

5.0

0.07

506

2208

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

237

914

1.48

7.14

1.4

1.3

pmol/l

263.2

254.3

0.16

173

675

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

109

345

1.81

7.13

1.3

1.2

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

507

2227

1.31

7.06

1.7

1.8

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

295

1191

1.42

7.02

4.3

4.4

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

1683

8372

1.16

6.99

2.2

2.5

g/l

0.2

0.49

1565

7713

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

827

3861

1.23

6.96

3.0

3.1

u/ml

0.3

0.19

480

2170

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

954

4520

1.21

6.96

3.1

2.9

0.7

0.15

919

4343

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

262

1.92

6.94

6.9

7.2

—

(3024869) Neuronal Ab [Presence] in Serum

165

2.18

6.94

1.2

1.1

—

(3000475) Leukocytes [#/volume] in Synovial fluid

495

2173

1.31

6.93

1.5

1.6

e6/l

18017.8

17672.7

0.03

372

1586

(3000034) Microalbumin [Mass/volume] in Urine

216

823

1.50

6.91

3.4

3.0

mg/l

74.5

54.1

0.31

179

609

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

800

3725

1.23

6.91

2.2

2.5

ug/l

361.1

702.1

4.26

765

3575

(3011985) Renin [Units/volume] in Plasma

252

993

1.45

6.84

1.5

1.4

mu/l

71.8

81.1

0.27

217

886

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

975

4639

1.21

6.82

3.1

2.9

1.2

1.3

1.80

969

4617

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

2.86

6.79

2.8

2.0

u/field

0.2

0.05

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

1242

6049

1.18

6.72

7.4

8.4

mmol/l

24.6

0.05

1233

5994

(3014111) Lactate [Moles/volume] in Serum or Plasma

1802

9044

1.15

6.63

7.2

8.2

mmol/l

1.4

2.41

1718

8704

(3003181) Sodium [Moles/volume] in Urine

317

1310

1.39

6.62

1.3

mmol/l

64.7

63.3

0.21

259

1042

(3011412) CD3 cells [#/volume] in Blood

200

758

1.51

6.59

2.6

2.5

e9/l

1.1

1.0

0.18

124

446

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

112

367

1.74

6.57

6.1

5.5

u/ml

67.7

41.3

0.46

115

(3000991) Gas panel - Venous blood

1738

8709

1.15

6.54

8.7

9.7

—

(3020961) Endomysium IgA Ab [Titer] in Serum

514

2289

1.29

6.50

1.1

titre

232.0

257.2

0.07

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

264

1061

1.43

6.48

1.1

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

481

2127

1.30

6.42

1.8

1.9

mg/l

12.9

11.2

1.01

445

1995

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

417

1812

1.32

6.32

1.7

1.6

—

(3032057) Clostridioides difficile [Presence] in Stool

146

2.19

6.27

1.7

2.0

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

348

1475

1.35

6.25

1.2

1.1

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

562

2545

1.27

6.23

2.3

2.5

g/l

0.0

0.24

511

2316

(3019832) Treponema pallidum Ab [Presence] in Serum

549

2482

1.27

6.18

1.8

1.5

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

249

1.88

6.16

1.7

2.5

u/l

1.2

92.9

0.82

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

157

575

1.56

6.07

1.2

mmol/l

2.0

2.2

1.10

145

532

(3019977) pH of Arterial blood

153

557

1.57

6.06

2.1

2.6

7.4

0.45

200

(4146454)

249

1005

1.42

6.00

2.6

2.8

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

172

649

1.52

5.84

1.2

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

386

1682

1.32

5.78

1.6

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

348

1496

1.33

5.73

2.7

2.9

u/ml

24765.7

4656.4

0.42

105

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

361

1561

1.33

5.71

1.4

1.3

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

228

915

1.43

5.70

1.7

2.0

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

572

4019

0.81

5.67

1.5

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

497

2250

1.27

5.57

1.6

1.5

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

102

344

1.69

5.49

2.6

2.4

—

(4211845)

104

353

1.68

5.47

3.1

2.7

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

556

2560

1.25

5.41

1.1

1.2

iu/ml

119.2

107.3

0.27

184

836

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

140

515

1.55

5.36

1.1

1.2

u/ml

41.0

33.3

—

(4015189)

253

1.81

5.36

1.8

2.0

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

546

2513

1.25

5.33

2.3

2.5

g/l

0.0

0.00

506

2313

(42529406) Shigella sp [Presence] in Stool by Culture

406

1803

1.29

5.32

1.2

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

236

966

1.40

5.31

1.7

1.9

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

142

526

1.54

5.28

2.3

2.1

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

146

545

1.53

5.25

1.7

1.6

u/ml

24.9

30.1

0.63

116

(1175426) CD3 cells/100 lymphocytes in Blood

151

568

1.52

5.25

2.2

2.0

70.6

71.0

0.09

142

541

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

210

1.88

5.21

1.7

2.5

ug/l

0.8

0.9

0.03

199

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

225

917

1.40

5.20

2.1

2.2

titre

1142.9

3292.4

1.01

(3006462) Nitrate [Presence] in Urine

324

1.69

5.18

3.2

2.8

—

(3052592) Norovirus Ag [Presence] in Stool

147

2.06

5.17

1.3

—

(3051593) INR in Capillary blood by Coagulation assay

131

479

1.56

5.17

11.6

11.0

—

(3010375) cycloSPORINE [Mass/volume] in Blood

123

444

1.58

5.13

31.6

28.4

ug/l

117.9

120.9

0.20

107

367

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

187

1.92

5.12

1.1

1.3

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

385

1708

1.29

5.11

1.7

1.8

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

468

2129

1.26

5.08

1.6

iu/ml

37.5

4.8

0.84

110

491

(3014765) Yersinia sp identified in Stool by Organism specific culture

403

1803

1.28

5.02

1.2

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

204

825

1.41

4.95

1.4

1.3

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

545

2531

1.23

4.94

3.0

mg/l

1.7

1.00

486

2322

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

246

1031

1.37

4.85

1.3

1.6

iu/l

4.1

23.3

0.78

313

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

708

3383

1.20

4.84

3.2

3.9

u/ml

316.6

2328.4

1.74

629

2948

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

216

1.82

4.82

1.3

1.2

nmol/l

122.7

147.4

0.60

158

(3016018) Differential panel - Cerebral spinal fluid

191

768

1.42

4.80

1.3

1.4

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

146

557

1.50

4.79

2.2

2.0

16.3

16.0

0.06

214

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

2.45

4.78

2.5

2.2

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

139

525

1.51

4.78

2.5

2.6

e6/l

562.4

524.3

0.22

123

455

(3029634) Reagin Ab [Titer] in Serum by VDRL

251

1060

1.36

4.73

2.6

titre

7.6

3.6

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

1490

7559

1.13

4.71

2.5

2.7

u/l

36.2

64.9

1.63

1285

6552

(3003338) MCHC [Mass/volume]

12072

67079

1.07

4.71

24.6

20.1

g/l

334.2

0.33

11969

66489

(3016038) Potassium [Moles/volume] in Urine

130

487

1.53

4.66

1.1

mmol/l

34.6

36.9

0.55

115

423

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

133

501

1.52

4.65

2.6

2.7

e9/l

0.3

0.2

0.50

123

454

(3017354) Segmented neutrophils/100 leukocytes in Blood

229

957

1.37

4.62

3.6

58.4

59.5

0.24

164

593

(3036670) Protein [Mass/volume] in Synovial fluid

271

1.71

4.56

1.2

1.3

g/l

40.4

41.4

0.24

159

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

396

1794

1.26

4.50

1.2

—

(3021788) Differential panel - Synovial fluid

360

1616

1.28

4.42

1.4

1.5

—

(3017569) Oxygen content in Arterial blood

127

480

1.51

4.39

2.1

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

107

391

1.56

4.31

1.1

nmol/l

8.1

6.5

0.27

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

308

1360

1.30

4.31

1.6

—

(3036603) Volume of Urine

149

585

1.46

4.30

2.0

1.8

1936.7

1989.9

0.13

146

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

119

2.06

4.28

1.2

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

243

1.72

4.22

7.0

5.5

66.5

72.4

0.79

205

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

110

408

1.54

4.17

1.2

—

(3044242) Glucose [Moles/volume] in Arterial blood

124

473

1.50

4.14

2.0

1.9

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

115

432

1.52

4.12

1.1

mg/l

358.1

381.4

0.33

378

(40761539) Cells [Type] in Urine sediment by Light microscopy

215

1.75

4.11

1.2

1.3

—

(4094501)

563

2678

1.21

4.10

1.1

—

(3018133) Calcium [Moles/volume] in Urine

2.40

4.08

1.5

1.7

mmol/l

2.8

2.5

0.33

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

126

484

1.49

4.07

4.4

3.4

—

(3023419) Bacteria identified in Sputum by Culture

293

1297

1.29

4.05

2.4

2.1

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

245

1060

1.32

4.00

1.3

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

309

1380

1.28

3.99

1.5

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

100

2.11

3.93

1.1

umol/24h

0.8

1.3

0.40

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

120

460

1.49

3.93

1.2

1.1

mg/l

50.2

56.2

0.47

386

(3027456) Digoxin [Moles/volume] in Serum or Plasma

372

1703

1.25

3.93

3.0

2.8

nmol/l

0.8

0.76

264

1283

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

2.27

3.89

2.5

2.1

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

214

912

1.34

3.88

1.3

e6/l

133535.9

95770.4

0.34

154

632

(3042631) Mycobacterium sp identified in Specimen

329

1490

1.26

3.82

2.9

2.4

—

(3020876) Protein [Mass/time] in 24 hour Urine

214

915

1.34

3.81

1.9

2.0

g/24h

1.6

0.8

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

242

1.68

3.81

1.2

1.1

—

(3010503) CD19 cells [#/volume] in Blood

134

529

1.45

3.81

2.8

2.6

e9/l

0.1

0.4

0.91

129

512

(40768446) Kidney Pathology biopsy report

104

390

1.52

3.79

1.7

1.6

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

208

1.73

3.78

1.1

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

1447

7435

1.12

3.75

1.7

1.6

—

(3000012) Reticulocyte production index

130

512

1.45

3.74

1.4

1.6

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

1456

7491

1.12

3.70

1.6

1.5

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

449

2114

1.22

3.68

1.7

1.6

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

1146

5815

1.13

3.67

9.0

10.7

mmol/l

24.1

24.2

0.20

1054

5417

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

147

1.86

3.67

1.1

—

(44790049)

240

1051

1.31

3.64

1.6

—

(44790047)

240

1051

1.31

3.64

1.6

—

(44806118)

240

1051

1.31

3.64

1.6

—

(44790048)

240

1051

1.31

3.64

1.6

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

199

849

1.34

3.62

1.5

1.4

u/l

12.7

13.1

0.28

186

820

(3004716) Salmonella sp identified in Stool by Organism specific culture

493

2347

1.20

3.61

1.3

—

(3026470) Cobalt [Mass/volume] in Blood

155

636

1.39

3.59

2.0

1.9

ug/l

3.8

3.1

0.39

134

553

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

311

1412

1.26

3.56

1.1

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

2.56

3.56

1.2

1.3

umol/24h

299.2

385.3

1.32

(3025577) Chromium [Mass/volume] in Blood

150

614

1.40

3.53

2.0

ug/l

2.3

1.8

0.74

116

523

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

132

529

1.43

3.50

4.3

3.4

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

271

1.60

3.47

2.4

1.9

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

188

801

1.34

3.46

1.1

—

(3012989) Citrate [Moles/time] in 24 hour Urine

4.39

3.42

1.6

1.0

mmol/24h

2.2

2.5

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

260

1.60

3.36

1.7

1.3

nmol/l

0.1

0.53

219

(3018405) Lactate [Moles/volume] in Arterial blood

747

3708

1.16

3.34

4.3

4.8

mmol/l

1.3

1.5

3.54

732

3640

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

185

792

1.34

3.32

1.2

1.1

au/ml

14.6

8.2

1.11

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

140

1.84

3.32

4.5

4.9

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

367

1713

1.23

3.31

1.5

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

194

837

1.33

3.31

1.7

1.8

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

194

837

1.33

3.31

1.7

1.8

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

194

837

1.33

3.31

1.7

1.8

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

326

1503

1.24

3.30

1.4

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

128

1.87

3.29

1.1

umol/l

2.7

3.0

0.21

118

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

152

632

1.37

3.29

1.0

1.1

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

398

1875

1.22

3.28

1.3

1.2

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

2.30

3.28

6.6

4.5

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

174

740

1.34

3.27

1.4

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

350

1629

1.23

3.25

1.3

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

187

806

1.33

3.22

1.3

1.2

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

621

3050

1.17

3.21

1.9

1.7

—

(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood

241

1.61

3.21

2.1

2.0

33.8

31.4

0.48

222

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

437

2083

1.20

3.20

3.3

3.6

u/ml

633.7

1102.5

0.55

407

1892

(3008898) HLA-B27 [Presence]

327

1514

1.24

3.20

1.1

1.0

—

(40762814) Titanium [Mass/volume] in Blood

159

1.76

3.18

2.4

ug/l

4.5

3.5

0.24

(3041918) Cholesterol [Moles/volume] in Pleural fluid

202

1.67

3.18

1.3

1.2

mmol/l

1.6

1.5

0.16

133

(3001019) Free T4 and TSH panel - Serum or Plasma

293

2064

0.81

3.16

1.3

1.5

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

430

2050

1.20

3.15

1.5

g/l

1.1

1.2

0.72

407

1955

(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay

2.28

3.11

1.4

1.1

pmol/l

13.7

14.0

0.02

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

204

897

1.30

3.07

1.2

1.1

mmol/l

7.2

7.7

1.16

149

648

(3023410) Appearance of Cerebral spinal fluid

163

695

1.34

3.04

1.5

—

(3006245) CD3-CD19+ cells/100 cells in Blood

236

1.60

3.02

2.0

8.4

10.6

0.67

214

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

414

1976

1.20

3.02

1.5

1.4

g/l

0.2

0.95

389

1881

(3020491) Glucose [Moles/volume] in Blood

141

589

1.37

3.00

2.0

1.9

mmol/l

7.1

7.4

0.67

100

416

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

248

1122

1.26

3.00

1.7

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

219

1.62

2.99

1.1

1.0

u/ml

2.4

6.0

0.82

(3042010) Triglyceride [Moles/volume] in Pleural fluid

158

1.73

2.99

1.3

1.2

mmol/l

0.4

1.2

1.10

105

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

106

422

1.44

2.97

1.1

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

233

1.59

2.96

1.6

1.7

nmol/l

9.5

3.7

0.44

205

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

108

432

1.43

2.96

1.6

1.3

u/l

7.6

6.4

0.35

369

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

354

2426

0.83

2.92

3.0

2.6

198.3

206.5

0.94

334

2315

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

138

1.78

2.92

1.3

1.4

pmol/l

14.4

16.9

1.09

116

(3045142) Bone marrow Pathology biopsy report

249

1132

1.26

2.90

1.4

1.3

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

311

1450

1.23

2.89

1.3

1.4

—

(3008295) Osmolality of Serum or Plasma

178

776

1.31

2.88

1.4

1.3

mosm/kgh2o

280.9

281.0

0.02

140

639

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

135

565

1.37

2.86

3.0

2.7

34.1

35.8

0.31

174

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

212

947

1.28

2.86

1.2

u/ml

49.0

36.2

—

(3026250) Tacrolimus [Mass/volume] in Blood

110

445

1.41

2.84

36.8

34.2

ug/l

7.4

7.5

0.22

100

402

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

2.38

2.84

1.1

1.0

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

182

798

1.30

2.83

1.6

1.5

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

114

466

1.40

2.79

1.3

titre

657.8

473.5

—

(3022689) Creatine [Moles/volume] in Urine

246

1.56

2.78

1.6

1.4

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

362

1.45

2.77

1.1

u/l

19.4

36.3

2.16

269

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

362

1.45

2.77

1.1

u/l

75.2

101.5

2.63

286

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

172

751

1.31

2.76

1.1

iu/ml

2.3

—

(3004451) EKG impression Narrative

119

491

1.38

2.76

1.3

—

(3051611) Lipemic interference index of Serum or Plasma

198

882

1.28

2.74

3.1

4.2

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

156

674

1.32

2.71

1.3

1.2

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

288

1343

1.23

2.70

1.4

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

253

1.53

2.68

1.0

—

(21494815) CD4 cells/100 lymphocytes in Specimen

172

755

1.30

2.67

2.1

38.3

37.7

0.06

(3006442) Creatine [Moles/volume] in Serum or Plasma

151

652

1.32

2.64

1.6

umol/l

79.9

79.6

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

2.28

2.63

1.3

1.1

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

2.22

2.60

1.2

1.0

u/l

10.4

7.7

0.36

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

182

810

1.28

2.57

1.1

—

(3003129) Base excess in Capillary blood by calculation

270

1.50

2.55

1.9

1.6

mmol/l

-0.5

0.3

1.01

260

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

140

1.71

2.55

1.2

ng/l

243.7

163.0

0.21

102

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

109

450

1.38

2.55

1.2

1.3

titre

46.0

96.1

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

3.95

2.55

1.3

2.1

—

(3000060) B lymphocytes [#/volume] in Blood

149

1.69

2.53

1.9

2.0

e6/l

629.0

2020.2

0.39

(21494890) Protein electrophoresis panel - 24 hour Urine

248

1149

1.23

2.50

2.4

2.0

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

185

1.60

2.49

2.1

2.8

mmol/l

8.2

8.6

0.22

109

(3018851) Theophylline [Moles/volume] in Serum or Plasma

1.95

2.45

1.4

1.6

umol/l

47.6

44.9

0.14

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

2.75

2.43

1.4

1.8

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

2.52

2.41

2.3

1.2

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

150

658

1.30

2.39

1.2

u/ml

58.2

45.0

—

(3006576) Bicarbonate [Moles/volume] in Blood

108

451

1.37

2.38

7.7

6.6

mmol/l

25.5

25.0

0.50

411

(37021550) Renin [Units/volume] in Plasma --upright

152

1.65

2.37

1.4

1.3

mu/l

69.4

72.5

0.04

124

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

113

476

1.36

2.37

1.8

2.3

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

929

4791

1.11

2.37

4.5

mmol/l

23.9

0.02

833

4272

(21494814) CD8 cells/100 lymphocytes in Specimen

327

1.43

2.36

2.3

2.0

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

235

1091

1.23

2.35

3.6

3.5

nmol/l

8.5

7.1

0.20

230

1071

(3017817) Protein [Mass] in Urine collected for unspecified duration

218

1004

1.24

2.35

2.5

2.4

—

0.7

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

113

477

1.35

2.34

1.8

2.3

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

113

477

1.35

2.34

1.8

2.3

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

113

477

1.35

2.34

1.8

2.3

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

323

1.43

2.33

2.7

2.4

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

371

1.40

2.32

1.9

2.5

—

(3030905) Polymorphonuclear cells [#/volume] in Blood

326

1566

1.19

2.31

3.5

3.4

e9/l

4.4

4.3

0.21

326

1560

(3000093) Morphology [Interpretation] in Blood Narrative

209

961

1.24

2.29

1.1

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

226

1.52

2.29

1.2

32.4

34.7

0.16

155

(3014148) Varicella zoster virus Ab [Titer] in Serum

168

753

1.27

2.28

1.1

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

319

1532

1.19

2.27

1.3

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

141

1.66

2.26

1.8

1.9

ng/l

200.0

161.1

0.46

141

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

150

1.64

2.25

1.1

1.3

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

152

674

1.29

2.25

2.6

2.5

e6/l

613.8

535.4

0.58

262

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

177

1.58

2.24

1.2

pmol/l

246.1

244.1

0.02

137

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

2.11

2.24

1.0

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

210

969

1.24

2.24

1.3

—

(3001729) Color of Synovial fluid

1.99

2.22

1.3

—

(3011544) Albumin [Mass/volume] in Pleural fluid

116

1.72

2.21

1.1

1.2

g/l

18.2

16.2

0.85

105

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

151

1.63

2.20

1.3

1.2

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

178

1.57

2.20

1.5

1.4

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

1809

11015

0.93

2.17

1.9

1.6

0.56

1546

9537

(3020123) Porphyrins [Interpretation] in Serum or Plasma

2.56

2.16

1.5

1.2

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

3.00

2.16

3.4

3.3

—

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

267

1.45

2.15

1.4

19.9

23.4

0.49

226

(3009015) Lactate [Moles/volume] in Synovial fluid

1.83

2.09

1.4

1.2

mmol/l

6.6

7.2

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

149

1.61

2.09

1.2

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

339

1651

1.17

2.08

2.1

1.9

ug/l

26.2

27.4

0.10

332

1618

(3047189) Immunofixation for 24 hour Urine

123

538

1.31

2.05

1.6

1.8

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

141

1.62

2.04

1.1

—

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

141

1.62

2.04

1.4

1.2

u/l

37.9

288.6

0.52

105

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

128

1.65

2.03

1.5

2.2

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

375

0.65

2.02

1.6

2.1

e6/l

22726.9

5676.7

0.55

218

(3006270) Folate [Moles/volume] in Blood

150

675

1.27

2.02

1.2

nmol/l

328.8

346.4

0.45

112

543

(4027681)

324

1.39

2.00

1.3

—

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

1.76

1.99

1.0

1.1

iu/ml

7.2

20.1

1.13

(40763480) Human metapneumovirus Ag [Presence] in Specimen

2.35

1.99

1.4

1.6

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

402

1.35

1.99

1.2

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

107

1.71

1.99

1.4

1.6

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

197

917

1.23

1.98

1.4

1.3

u/l

15.6

13.9

0.33

187

855

(3027944) Amphetamines [Presence] in Urine

197

1366

0.82

1.97

2.1

1.9

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

162

739

1.25

1.96

1.4

1.3

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

369

1.36

1.96

2.0

2.5

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

297

1.40

1.94

2.0

2.7

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

297

1.40

1.94

2.0

2.7

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

370

1.36

1.93

2.0

2.5

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

336

1.38

1.93

1.4

1.5

umol/l

61.3

96.2

1.71

155

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

147

665

1.26

1.91

1.5

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

420

1.33

1.91

1.1

—

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

284

1.41

1.90

2.9

2.0

u/l

55.1

39.9

0.26

263

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

294

1429

1.18

1.88

1.3

u/ml

272.8

279.1

0.14

189

933

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

2.85

1.87

1.0

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

2.85

1.87

1.1

1.0

—

(3043409) Potassium [Moles/volume] in Arterial blood

624

3196

1.12

1.87

4.6

5.1

mmol/l

3.9

4.0

0.84

581

3005

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

100

0.40

1.86

1.3

1.1

—

(3035637) Corticotropin [Mass/volume] in Plasma

208

981

1.21

1.86

1.5

1.6

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

2.12

1.84

1.3

1.1

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

127

568

1.28

1.83

1.3

1.4

iu/l

10.2

10.0

0.09

103

448

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

1.78

1.81

1.4

1.6

ug/l

0.3

0.4

0.48

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

128

576

1.27

1.77

1.2

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

2.14

1.77

8.3

10.6

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

101

441

1.31

1.75

1.5

1.4

65.0

62.5

0.28

356

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

167

776

1.23

1.75

1.2

u/l

64.8

66.9

0.08

524

(3023487) Leukocytes [#/volume] in Peritoneal fluid

423

0.70

1.75

1.9

2.2

e6/l

8008.2

3968.2

0.22

301

(3001893) Eosinophils/100 leukocytes in Pleural fluid

382

1.33

1.74

1.4

1.5

2.4

0.84

310

(3023430) Cat dander IgE Ab [Units/volume] in Serum

114

507

1.28

1.73

1.0

u/ml

1.1

2.9

2.22

195

(3024928) Oxygen saturation in Venous blood

437

2203

1.13

1.73

3.4

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

140

639

1.25

1.73

1.1

u/ml

3.0

4.1

0.57

279

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

319

1.36

1.72

1.1

u/l

1.1

1.2

0.50

169

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

239

1153

1.18

1.71

1.4

1.3

u/l

369.1

622.5

2.10

224

1106

(40768793) Breast Pathology biopsy report

1.84

1.69

1.0

1.1

—

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

1297

6912

1.08

1.67

9.3

10.6

0.6

0.08

1287

6863

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

1.77

1.66

3.1

4.5

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

433

2191

1.13

1.64

1.7

mg/l

4.4

4.0

0.17

310

1571

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

288

1.37

1.63

1.1

1.2

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

235

1.41

1.63

1.3

1.2

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

212

1.43

1.60

2.3

2.5

—

(3028717) Thiamine [Mass/volume] in Blood

1.75

1.60

1.0

1.1

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

101

733

0.78

1.59

1.3

1.2

titre

77.4

134.3

1.38

115

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

172

811

1.21

1.59

2.3

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

115

1.59

1.57

1.4

1.0

u/l

16.5

17.4

0.13

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

423

2708

0.89

1.57

2.4

2.3

87.5

85.6

1.11

395

2579

(3020891) Body temperature

795

4167

1.09

1.56

5.6

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

276

1.37

1.56

3.2

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

2.70

1.55

1.1

1.0

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

192

918

1.19

1.55

1.4

1.5

28.1

24.2

0.84

127

598

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

1293

6916

1.07

1.53

9.2

10.4

1.3

1.4

2.04

1283

6862

(3044007) Cell count panel - Peritoneal fluid

330

0.69

1.50

2.2

1.9

—

(3024471) HLA-A [Type]

387

1.30

1.50

1.0

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

264

1.36

1.48

1.1

1.0

iu/ml

8.9

9.5

0.07

(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid

3.57

1.48

1.2

1.1

mg/l

1.8

1.6

—

(3012565) Volume of 24 hour Urine

104

469

1.27

1.47

2.3

2.5

1964.5

2022.3

0.24

411

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

349

1757

1.14

1.47

1.7

1.5

—

(3016879) Cocaine [Presence] in Urine

197

1322

0.85

1.46

2.1

2.0

—

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

164

1.46

3.7

6.0

u/l

41.8

61.1

0.53

(3023383) Lactate [Moles/volume] in Pleural fluid

354

1.31

1.45

1.4

mmol/l

3.6

0.01

329

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

126

582

1.24

1.45

1.5

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

300

1.33

1.44

1.5

1.3

u/l

11.0

12.1

0.25

251

(44806420)

271

1.35

1.42

2.4

2.3

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

136

635

1.22

1.42

1.0

u/ml

0.5

1.8

2.20

151

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

137

1.50

1.41

1.2

—

(3040794) Aluminum [Moles/volume] in Urine

0.00

1.40

0.0

1.4

—

(3027008) Opiates [Presence] in Urine

209

1390

0.86

1.40

2.0

1.8

—

(3029075) Extractable nuclear Ab panel - Serum

180

1.43

1.39

1.0

—

(3027540) Rickettsia typhi Ab [Titer] in Serum

2.85

1.39

1.0

1.1

—

(40757373) Influenza virus identified in Isolate

185

1.42

1.38

1.7

1.9

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

481

2478

1.11

1.38

1.6

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

398

1.28

1.36

1.7

1.3

u/ml

2.2

1.7

0.21

217

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

158

753

1.20

1.36

2.2

1.8

mg/l

4.3

4.0

0.24

149

718

(3024932) HLA-DR beta [Type]

384

1.28

1.34

1.1

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

2.54

1.34

1.5

1.0

3.9

2.7

—

(3000764) Benzodiazepines [Presence] in Urine

208

1378

0.86

1.33

2.0

1.9

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

314

0.71

1.31

1.2

1.6

g/l

15.6

11.8

1.41

245

(3037556) Urate [Mass/volume] in Serum or Plasma

300

1.31

1.7

1.4

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

170

819

1.19

1.31

1.1

u/ml

1.7

1.6

0.05

338

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

125

585

1.22

1.30

1.5

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

248

1232

1.15

1.30

4.2

4.7

umol/l

346.6

350.6

0.17

214

1037

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

345

1752

1.13

1.30

1.6

1.5

u/ml

20.2

15.7

0.33

(3002331) Protein [Mass/volume] in Peritoneal fluid

273

0.69

1.29

1.6

1.3

g/l

23.9

43.8

0.47

217

(3028300) Cannabinoids [Presence] in Urine

211

1391

0.86

1.28

2.0

1.9

—

(3018840) Calcitonin [Moles/volume] in Serum or Plasma

1.90

1.27

1.9

2.5

pmol/l

153.8

31.1

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

113

525

1.23

1.27

1.3

nmol/l

1.1

1.3

0.75

398

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

2.09

1.26

1.1

—

(3045716) Anion gap in Serum or Plasma

454

1.24

1.26

2.3

2.1

mmol/l

8.7

9.2

0.61

345

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

166

802

1.18

1.25

1.1

1.2

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

1.56

1.24

1.2

1.3

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

1.56

1.24

1.2

1.3

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

1.56

1.24

1.2

1.3

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

1.63

1.24

1.9

2.0

—

(3001556) Androgen free Index in Serum or Plasma

2.28

1.24

1.3

1.5

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

214

1.36

1.23

1.6

1.9

—

(3034459) Mononuclear cells/100 leukocytes in Pleural fluid

123

1.48

1.23

1.6

1.3

72.0

70.4

0.10

101

(3012494) Peanut IgE Ab [Units/volume] in Serum

1.60

1.21

1.1

1.0

u/ml

0.6

0.01

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

324

1.29

1.21

1.1

—

(4133840)

279

1.31

1.21

1.2

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

1.71

1.21

1.8

1.2

—

(3036782) Glucose [Moles/volume] in Pleural fluid

229

1140

1.15

1.19

1.4

mmol/l

6.4

6.2

0.37

209

1052

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

320

1.28

1.19

1.7

1.5

u/ml

4417.9

12129.9

—

(21494434) Karyotype in Bone marrow

188

924

1.16

1.17

1.2

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

459

1.23

1.16

1.2

1.3

u/l

651.3

369.3

0.41

426

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

2.50

1.16

1.1

1.0

mmol/l

8.9

9.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

413

1.24

1.16

1.1

1.2

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

413

1.24

1.16

1.1

1.2

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

413

1.24

1.16

1.1

1.2

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

1.56

1.15

1.9

2.5

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

312

1590

1.12

1.14

1.7

1.5

u/ml

110.3

0.00

330

(3051651) Icteric interference index of Serum or Plasma

116

548

1.21

1.14

3.1

4.9

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

198

1.35

1.13

1.5

ug/l

9.9

10.3

0.16

198

(4062490)

156

758

1.18

1.13

1.2

1.5

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

1.70

1.13

1.3

1.2

—

(3033799) Differential panel - Peritoneal fluid

363

0.75

1.12

2.0

2.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

410

1.24

1.12

1.1

1.2

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

410

1.24

1.12

1.1

1.2

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

410

1.24

1.12

1.1

1.2

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

179

1.37

1.11

1.3

1.4

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

359

1.26

1.11

2.2

2.3

umol/l

52.0

56.6

0.91

296

(3042733) HLA Ab [Presence] in Serum

405

1.24

1.11

5.6

4.7

—

(3000919) Neutrophils/100 leukocytes in Pleural fluid

339

1.26

1.11

1.4

21.6

22.4

0.08

299

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

1.72

1.11

1.1

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

194

1.35

1.10

1.1

1.3

105.3

110.9

0.58

175

(3001186) Copper [Moles/volume] in Serum or Plasma

165

1.38

1.10

1.0

1.1

umol/l

15.1

15.6

0.49

151

(3004775) Volume in Urine collected for unspecified duration

191

946

1.15

1.09

2.4

2.3

708.9

694.1

0.18

125

619

(3016244) Insulin [Units/volume] in Serum or Plasma

249

1.31

1.09

1.9

3.3

mu/l

18.1

29.4

1.66

232

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

1.67

1.07

1.1

mmol/l

10.0

11.4

—

(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood

1.52

1.06

1.2

1.3

ml/s/173m2

1.2

1.1

0.17

(3035320) C reactive protein [Mass/volume] in Body fluid

114

543

1.20

1.05

3.0

2.5

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

1.69

1.05

1.0

1.2

umol/24h

2.3

2.1

0.13

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

605

3714

0.93

1.04

1.2

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

143

696

1.17

1.04

1.0

1.1

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

425

1.22

1.03

1.0

1.1

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

120

576

1.19

1.02

1.8

1.9

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

1.90

1.02

1.2

1.1

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

2.10

1.02

5.0

5.5

—

(3036489) Thrombin time

525

3235

0.92

1.00

2.2

2.1

22.1

22.2

0.07

470

2912

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

144

1.39

0.99

1.3

1.1

mg/l

54.5

69.0

0.08

104

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

1.66

0.99

1.1

1.0

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

240

1535

0.89

0.99

1.1

iu/ml

543.4

57.4

0.47

279

(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma

1.77

0.98

1.1

1.2

u/l

58.6

203.2

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

299

1.26

0.98

2.1

2.4

ug/l

515.0

481.9

0.02

289

(40765096) Chromosome analysis panel by Banding

294

1.26

0.98

1.2

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

177

881

1.15

0.98

1.5

1.4

promille

1.2

1.5

2.08

148

675

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

269

1.27

0.97

1.1

miu/ml

1341.7

1576.4

0.96

269

(3034274) Bile acid [Moles/volume] in Serum --fasting

199

1.32

0.97

1.0

1.3

umol/l

34.6

20.5

0.30

142

(3022493) Free Hemoglobin [Mass/volume] in Plasma

444

1.21

0.97

5.3

7.0

mg/l

1711.5

2856.8

0.25

323

(3009677) Dengue virus Ab [Presence] in Serum

2.00

0.96

1.4

1.1

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

107

513

1.19

0.95

1.1

—

(3044941) Cell count panel - Synovial fluid

274

1407

1.11

0.93

1.3

1.4

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

107

514

1.19

0.93

1.1

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

256

1.27

0.92

1.0

1.1

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

161

1.35

0.92

1.2

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

113

546

1.18

0.92

1.0

u/ml

1.0

3.3

3.09

215

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

159

790

1.15

0.92

1.8

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

237

1210

1.12

0.90

1.4

1.3

pmol/l

67.2

100.9

0.73

101

390

(1617658) Protocol used for examination of sentinel lymph nodes

2.14

0.90

1.0

1.1

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

422

1.20

0.90

1.4

1.5

—

(3009871) Measles virus Ab [Titer] in Serum

259

0.75

0.88

1.6

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

428

1.20

0.88

1.6

1.5

4.7

3.0

0.55

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

345

1.22

0.88

1.1

—

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

1.48

0.88

1.3

1.1

ug/l

108.0

101.9

0.08

(3003434) Protein [Mass/volume] in Pleural fluid

322

1675

1.10

0.87

1.5

g/l

32.2

32.9

0.42

289

1504

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

1.69

0.86

1.1

1.2

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

188

1.31

0.86

1.3

1.6

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

212

0.73

0.86

1.1

—

(44813793)

342

1.22

0.84

1.1

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

342

1.22

0.84

7.0

8.8

—

(3024263) Appearance of Synovial fluid

107

520

1.17

0.84

1.5

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

457

1.19

0.84

1.5

1.6

u/l

8.3

7.3

0.20

230

(3021879) Hepatitis B virus core Ab [Presence] in Serum

902

4883

1.06

0.84

1.4

—

(3019174) dRVVT (LA screen)

1.63

0.83

1.0

1.2

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

152

760

1.14

0.83

1.2

1.5

g/l

0.4

0.5

0.18

105

527

(3017115) Methotrexate [Moles/volume] in Serum or Plasma

125

1.37

0.82

6.9

8.9

umol/l

0.3

0.45

114

(1001926) Buprenorphine [Presence] in Urine by Screen method

164

1058

0.88

0.82

2.3

2.0

—

(3003577) Lead [Moles/volume] in Blood

0.58

0.82

1.0

1.3

—

0.1

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

210

1.28

0.82

2.8

2.4

—

(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method

0.00

0.82

0.0

1.0

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

152

761

1.14

0.81

1.2

1.5

g/l

3.2

0.06

106

527

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

318

1.22

0.81

1.1

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

152

762

1.14

0.80

1.2

1.5

g/l

6.6

7.1

0.90

104

526

(3006922) Hepatitis E virus Ab [Presence] in Serum

112

549

1.16

0.80

1.1

—

(3011288) Drugs identified in Urine by Screen method

133

868

0.87

0.80

2.6

3.1

—

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

444

0.82

0.80

18.1

17.0

nmol/l

1379.9

1398.0

0.07

427

(3024980) IgG subclass 4 [Mass/volume] in Serum

242

1248

1.11

0.80

1.4

1.7

g/l

1.0

0.01

178

943

(44816559) Phosphatidylethanol [Mass/volume] in Blood

296

1542

1.10

0.80

1.6

1.5

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

329

1.21

0.80

3.2

2.9

umol/l

30.0

29.8

0.07

245

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

1.78

0.79

1.1

—

(40768795) Lymph node Pathology biopsy report

143

716

1.14

0.78

1.2

1.3

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

440

1.18

0.77

2.4

3.1

—

(40758047) Lysozyme [Mass/volume] in Pleural fluid

112

1.38

0.77

1.4

1.1

mg/l

9.2

8.2

0.21

103

(3034092) Cytoplasmic Ig cells/100 cells in Blood

1.43

0.76

7.7

9.0

—

(37019676) Renin [Units/volume] in Plasma --supine

2.19

0.76

1.0

mu/l

33.2

134.0

—

(40763590) HLA-DQ beta [Type]

1.71

0.76

1.0

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

182

1.29

0.76

1.6

1.4

6.2

11.2

1.27

(43055514) Macroprolactin [Presence] in Serum or Plasma

1.41

0.76

1.2

1.6

—

(3024316) Viscosity of Plasma

1.61

0.75

2.0

2.3

mpas

1.6

1.8

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

377

1992

1.08

0.75

1.3

—

(3008536) Aspergillus sp Ab [Presence] in Serum

208

1.26

0.75

1.6

2.5

—

(4281824)

340

0.80

0.74

1.2

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

377

1993

1.08

0.74

1.3

—

(40760409) HLA-A [Type] by High resolution

1.66

0.74

1.0

—

(40760410) HLA-B [Type] by High resolution

1.66

0.74

1.0

—

(3013862) HLA-DP [Type]

1.66

0.74

1.0

—

(46236302) HLA-C [Type] by High resolution typing

1.66

0.74

1.0

—

(3014891) Appearance of Pleural fluid

158

1.30

0.73

1.7

—

(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma

333

1.20

0.72

14.3

12.8

mmol/l

0.7

0.6

0.72

307

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

126

630

1.14

0.71

1.2

mmol/l

12.4

12.5

0.04

252

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

1.41

0.70

1.1

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

1.39

0.69

2.3

2.0

umol/l

18.6

18.1

0.10

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

1.54

0.68

1.1

1.0

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

1.90

0.68

1.2

1.1

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

388

1.18

0.68

2.2

2.1

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

211

1.24

0.68

1.1

1.3

g/l

0.3

0.97

170

(3035880) pH of Pleural fluid

139

703

1.13

0.68

1.4

1.3

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

1.66

0.67

1.0

1.1

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

1.50

0.67

10.4

5.2

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

1.41

0.67

1.0

1.1

—

(3020393) Adenovirus Ag [Presence] in Stool

1.43

0.64

1.1

—

(3041806) Other cells [#/volume] in Blood by Manual count

1.78

0.64

2.4

1.6

—

(3044009) aPTT.lupus sensitive (LA screen)

1.51

0.64

1.0

1.1

—

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

0.00

0.63

0.0

1.3

—

(3002814) Trichinella spiralis Ab [Titer] in Serum

0.00

0.63

0.0

1.0

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

388

0.84

0.63

1.5

1.3

—

(3016750) Collection duration of Urine

132

670

1.12

0.62

2.2

2.1

min

494.7

496.7

0.10

481

(3015350) Toxocara sp Ab [Presence] in Serum

0.00

0.62

0.0

1.0

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

144

735

1.12

0.62

1.0

1.1

u/ml

3.3

3.2

0.04

352

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

1.43

0.61

1.2

1.1

—

(3048879) Bone marrow aspiration report

324

1.18

0.61

1.7

—

(4306422)

172

1081

0.91

0.60

1.3

1.2

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

1.39

0.60

1.1

—

(3037297) Penicillin G IgE Ab [Units/volume] in Serum

1.80

0.60

1.0

—

0.2

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

344

2098

0.93

0.59

1.3

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

103

1.33

0.59

1.0

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

200

1.23

0.58

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

200

1.23

0.58

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

200

1.23

0.58

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

200

1.23

0.58

1.1

—

(3017509) Phencyclidine [Presence] in Urine

0.56

0.58

2.0

1.5

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

138

706

1.12

0.58

1.1

1.0

u/ml

0.9

1.1

0.14

276

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

190

1.23

0.58

1.4

1.1

—

(3026029) Penicillin V IgE Ab [Units/volume] in Serum

1.71

0.58

1.0

—

0.5

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

1.71

0.58

1.2

1.3

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

457

0.86

0.57

1.2

1.4

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

108

546

1.13

0.56

1.4

umol/l

15.2

14.7

0.26

100

520

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

217

1.21

0.56

1.0

1.1

—

(1002224) Polysomnography panel

548

3284

0.95

0.54

1.1

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

130

1.27

0.54

1.0

1.2

—

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

120

1.28

0.54

1.3

1.2

44.9

54.0

—

(1761868) Lipid panel - Serum or Plasma

5061

28465

1.02

0.54

3.4

3.1

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

366

1.15

0.53

1.1

—

(3001686) Cold agglutinin [Titer] in Serum or Plasma

156

1.24

0.53

1.6

1.4

titre

94.3

350.9

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

1.56

0.53

1.0

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

170

1060

0.91

0.53

1.2

1.1

111.0

0.00

151

966

(3028433) Virus identified in Specimen by Culture

271

1.18

0.53

1.2

—

(3051101) Glucose [Moles/volume] in Cord blood

188

1.21

0.51

6.5

6.1

—

(3025315) Body weight

0.71

0.51

5.5

4.9

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

183

1134

0.92

0.50

1.3

u/ml

4.6

3.8

0.17

436

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

1.60

0.50

1.0

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

142

1.25

0.50

2.3

2.5

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

449

1.13

0.50

1.0

u/ml

0.1

0.7

0.86

111

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

444

1.13

0.49

1.1

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

498

1.12

0.49

1.3

1.5

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

498

1.12

0.49

1.3

1.5

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

1.54

0.49

1.6

1.2

—

(44786800) Granulocytes/100 leukocytes in Body fluid

158

1.23

0.49

1.3

1.4

29.8

26.9

0.17

115

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

457

2741

0.95

0.49

2.6

g/l

3.5

3.7

2.07

431

2635

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

107

1.28

0.48

1.1

—

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

0.61

0.47

1.6

1.7

—

24.7

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

270

1.16

0.46

1.0

1.1

u/ml

5.0

6.1

—

(4198724)

212

1.18

0.45

1.8

2.4

—

(3046861) Legionella sp Ag [Presence] in Urine

1.38

0.44

1.0

1.1

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

197

1045

1.08

0.43

3.7

3.6

—

(3007463) Buprenorphine [Presence] in Urine

0.00

0.43

0.0

11.8

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

257

1377

1.07

0.43

1.1

1.2

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

1.58

0.43

1.4

1.3

nmol/l

125.6

619.1

—

(3020893) t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method

0.00

0.42

0.0

1.0

—

(3035933) Granulocytes/100 leukocytes in Blood

182

0.81

0.42

1.5

1.7

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

1.27

0.42

1.1

1.5

—

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

1.31

0.41

1.2

1.4

0.07

(3013293) Extractable nuclear Ab [Presence] in Serum

0.68

0.41

1.6

1.7

—

(40758292) HTLV I+II Ab panel - Serum

162

1.20

0.41

1.5

1.4

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

1.34

0.41

1.3

1.2

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

100

1.26

0.40

1.0

1.2

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

1.39

0.39

1.2

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

205

1.17

0.39

1.0

1.1

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

116

1.23

0.38

1.2

1.0

—

(3020874) Milk IgE Ab [Units/volume] in Serum

227

1.16

0.38

1.1

1.0

u/ml

0.9

0.7

0.30

(3042517) Benzodiazepines panel - Urine

1.43

0.38

2.0

2.5

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

1.32

0.38

1.0

1.5

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

526

2887

1.04

0.37

2.6

2.4

ug/min

103.8

134.9

1.08

326

1755

(3023199) Leukocytes [#/volume] in Pleural fluid

277

1497

1.06

0.37

1.5

e6/l

2790.6

3423.2

0.31

206

1082

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

1.25

0.37

2.3

2.0

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

122

1.22

0.37

1.2

1.0

—

(3013762) Body weight Measured

0.62

0.37

1.0

1.3

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

1.25

0.36

1.1

—

(40757494) Bilirubin.total [Moles/volume] in Blood

105

548

1.09

0.36

2.1

2.2

umol/l

19.8

44.2

—

(3000492) Spirometry study

1404

7834

1.02

0.35

1.6

1.5

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

102

1.23

0.35

1.0

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

1.30

0.35

1.1

1.0

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

1.31

0.34

4.2

3.5

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

192

1.16

0.34

1.0

1.1

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.24

0.34

1.0

1.1

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

189

0.84

0.34

2.9

3.0

mg/l

7.6

6.7

0.24

153

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

116

612

1.08

0.33

1.2

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

135

826

0.93

0.32

1.2

92.7

98.7

1.73

118

778

(3019897) Erythrocyte distribution width [Ratio] by Automated count

127

673

1.08

0.32

3.0

3.1

13.3

13.2

0.39

127

658

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

548

0.92

0.32

6.2

6.6

u/ml

485.1

1425.6

0.43

127

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

372

1.10

0.32

1.4

1.3

ug/l

572.0

121.9

0.71

186

(3005011) Chlamydia sp Ab [Titer] in Serum

1.29

0.31

1.6

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

340

1.11

0.31

1.0

1.1

ng/l

2406.1

329.0

1.13

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

1.29

0.30

15.4

10.0

—

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

104

1.21

0.30

3.3

3.4

mg/l

1.1

1.2

0.11

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

428

1.09

0.30

1.3

u/l

42.8

28.6

0.76

366

(3038071) Oxygen [Partial pressure] in Mixed venous blood

303

1.11

0.30

6.3

8.9

—

(3028707) Methadone [Presence] in Urine by Screen method

111

588

1.08

0.29

2.8

2.4

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

179

1080

0.94

0.29

1.2

1.1

—

(3036071) Salmonella sp Ab [Titer] in Serum

222

0.87

0.29

1.2

1.1

—

(3015956) Eosinophils/100 leukocytes in Blood by Manual count

1.30

0.29

2.0

1.5

1.4

1.9

—

(3002523) Influenza virus A Ag [Presence] in Specimen

146

885

0.94

0.28

1.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

146

885

0.94

0.28

1.1

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

118

0.82

0.28

1.1

—

(3023436) Glucagon [Mass/volume] in Serum or Plasma

1.31

0.27

1.5

1.7

ng/l

206.0

220.4

0.23

(3050794) Legionella sp Ab [Presence] in Serum

1.20

0.27

1.2

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

1.20

0.27

2.4

2.0

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

278

1.11

0.27

1.1

1.2

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

1.25

0.26

1.0

—

(3034770) Mitochondria Ab [Titer] in Serum

375

2066

1.04

0.26

1.2

titre

1152.2

880.4

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

449

1.08

0.25

1.3

u/l

126.7

107.6

0.43

386

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

168

909

1.05

0.25

1.2

miu/ml

150.2

174.8

0.30

247

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

1.19

0.25

1.1

1.0

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

247

1.11

0.25

7.1

7.2

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

179

972

1.05

0.24

1.2

1.3

nmol/l

1.4

0.12

155

887

(3029396) Erythrocyte agglutination [Presence] in Blood

1.36

0.24

1.0

1.1

—

(3034426) Prothrombin time (PT)

266

0.90

0.24

1.4

1.3

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

205

1.11

0.22

1.0

1.1

—

(3041672) Baker's yeast Ab [Presence] in Serum

1.24

0.22

1.0

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

0.00

0.22

0.0

1.0

—

(3030703) Everolimus [Mass/volume] in Blood

0.00

0.22

0.0

19.5

—

4.3

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

169

0.88

0.22

1.2

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

1.25

0.21

1.1

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

(36304079) Mucus [Presence] in Urine sediment

0.00

0.21

0.0

1.1

—

(3001488) Cow milk IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.3

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

130

1.14

0.21

1.0

1.2

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

132

0.86

0.21

1.2

1.1

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

150

0.87

0.21

1.6

1.9

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

168

0.88

0.21

1.1

81.1

77.8

0.29

103

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

1.21

0.21

1.1

1.3

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

1.22

0.20

1.0

—

(3019230) Fractional oxyhemoglobin in Venous blood

326

1804

1.03

0.20

3.0

2.9

64.9

65.9

0.34

326

1792

(3030313) Adrenal Ab [Titer] in Serum

1.18

0.20

1.0

1.1

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

191

1.11

0.19

3.3

—

(4034850)

465

2715

0.98

0.18

13.1

10.4

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

373

2183

0.97

0.18

1.4

1.5

nmol/l

0.9

0.11

299

1837

(40768441) Liver Pathology biopsy report

104

624

0.95

0.17

1.5

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

437

0.94

0.17

1.2

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

241

1331

1.03

0.17

1.1

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

290

0.92

0.17

1.1

98.8

103.2

0.52

235

(3051339) Copper [Moles/volume] in Blood

1.20

0.17

1.4

1.2

umol/l

17.8

15.8

—

(3013166) Neutrophils/100 leukocytes in Synovial fluid

320

1.07

0.16

1.3

59.7

61.4

0.12

280

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

199

1.09

0.16

1.1

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

376

0.94

0.15

1.1

1.2

ratio

1.1

0.12

124

(3014599) Egg white IgE Ab [Units/volume] in Serum

227

1.08

0.15

1.0

u/ml

0.3

0.8

2.37

(40768806) Pleura Pathology biopsy report

237

1313

1.03

0.15

1.6

1.5

—

(40765089) Chromosome analysis panel - Blood by G-banded

0.77

0.15

1.0

—

(3002619) Bacteria identified in Specimen by Culture

178

1.09

0.14

1.2

1.3

—

(3007566) Smooth muscle Ab [Titer] in Serum

379

2116

1.02

0.14

1.2

titre

82.1

107.7

0.76

207

(3004446) Plasmodium sp identified in Blood by Light microscopy

1.18

0.14

2.9

2.8

—

(3023183) Ammonium ion [Moles/volume] in Plasma

454

2541

1.02

0.14

2.2

2.9

umol/l

30.1

35.6

5.84

381

2150

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

187

1099

0.97

0.14

1.3

u/ml

4.1

0.00

532

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

190

1.08

0.13

1.0

1.1

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

0.83

0.13

1.4

1.3

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

229

1.07

0.13

1.4

1.3

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

344

0.94

0.13

1.2

1.1

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

1.14

0.12

1.0

ug/l

1.7

2.2

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

1.12

0.11

1.9

1.8

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

224

1308

0.98

0.11

1.1

—

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

167

0.92

0.11

1.6

au/ml

112.2

36.5

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

309

1.05

0.11

1.1

1.0

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

365

1.05

0.11

1.6

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

0.87

0.10

1.0

1.4

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

112

618

1.03

0.10

1.1

1.0

mg/l

271.8

277.5

0.38

572

(3015076) Soybean IgE Ab [Units/volume] in Serum

198

1.07

0.10

1.1

1.0

u/ml

0.5

—

(3000285) Sodium [Moles/volume] in Blood

119

0.91

0.10

1.1

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

204

1.06

0.10

1.1

—

(4212803)

1.10

0.10

1.2

1.1

—

(3004593) Baker's yeast IgA Ab [Units/volume] in Serum

1.06

0.09

1.0

—

26.2

—

(3008092) Baker's yeast IgG Ab [Units/volume] in Serum

1.06

0.09

1.0

—

32.3

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

248

1388

1.02

0.09

1.4

1.5

e6/l

66685.6

57950.4

0.18

150

869

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1.14

0.09

1.0

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

0.88

0.09

1.0

1.1

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

1.07

0.09

1.0

1.1

mmol/l

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

127

1.08

0.08

1.4

1.5

—

(44806071)

1.09

0.08

1.1

—

(3011325) HIV 1+2 Ab [Presence] in Serum

1.05

0.08

1.0

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

0.86

0.08

1.2

1.0

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

215

1205

1.02

0.07

1.1

g/l

1.5

1.6

0.30

192

1117

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

222

0.95

0.07

1.1

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

111

1.08

0.07

1.0

1.1

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

240

1391

0.98

0.07

2.7

2.9

u/ml

116.7

1005.9

1.15

234

1366

(3015183) Erythrocyte sedimentation rate

296

1.04

0.07

1.2

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

1.04

0.07

1.0

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

1.04

0.07

1.8

19.0

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

0.85

0.07

1.0

—

(3039744) RNA polymerase III Ab [Units/volume] in Serum

1.09

0.07

1.0

1.1

—

5.8

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

145

1.06

0.07

1.2

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

308

1.04

0.07

1.5

ug/l

16.2

7.9

0.61

283

(3019768) Coxiella burnetii Ab [Presence] in Serum

1.12

0.06

1.6

1.1

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

128

0.94

0.06

1.1

1.3

87.5

77.3

—

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

1.08

0.05

1.0

1.3

mg/l

41.1

45.4

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

1.07

0.05

1.1

1.0

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

0.93

0.04

1.2

—

(3045788) Cell count panel - Pleural fluid

204

1150

1.01

0.04

1.5

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

161

0.96

0.04

1.1

1.2

84.4

73.6

1.16

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

109

0.94

0.04

1.1

1.0

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

119

1.05

0.04

1.1

—

(43055442) Apixaban [Mass/volume] in Serum or Plasma

136

1.05

0.04

1.6

1.7

ug/l

116.1

119.8

0.06

107

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

108

1.06

0.04

1.2

—

(4268621)

127

732

0.99

0.02

2.5

2.4

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

132

1.04

0.02

1.0

1.1

—

(3012441) Differential panel - Pleural fluid

233

1337

0.99

0.02

1.5

—

(21491868) Cryoglobulin [Mass/volume] in Serum

274

1.02

0.02

1.2

g/l

0.2

0.7

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

216

0.98

0.02

1.1

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

0.95

0.01

1.2

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

124

0.97

0.01

1.5

3.3

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

345

1962

1.00

0.01

1.2

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

129

0.97

0.00

1.4

1.3

95.9

84.6

0.49

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

0.98

0.00

1.1

1.0

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

1.03

0.00

1.1

1.0

—

(3032868) Hemoglobin electrophoresis panel in Blood

1.03

0.00

1.6

1.4

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

213

0.99

0.00

1.6

2.0

mg/l

7.7

8.5

0.46

177

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

550

1.00

0.00

2.0

2.2

ug/min

117.5

117.8

0.00

146

(3036525) Urea [Moles/time] in 24 hour Urine

0.97

0.00

3.7

3.1

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

1.01

0.00

1.0

1.1

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

0.98

0.00

1.9

2.4

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

0.98

0.00

1.1

1.2

—

(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count

0.99

0.00

2.7

2.6

22.1

16.6

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

163

1.01

0.00

1.1

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

1.06

0.00

1.1

1.2

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.02

0.00

1.0

1.1

—

(3016184) Myelin associated glycoprotein Ab [Units/volume] in Serum

0.95

0.00

1.1

1.4

—

14605.4

—

(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid

113

1.01

0.00

2.5

61.9

55.8

0.28

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

1.02

0.00

2.0

2.2

mmol/l

0.9

1.0

—

(46235168) Fasting glucose [Moles/volume] in Blood

112

1.02

0.00

12.4

1.4

mmol/l

7.7

7.1

0.38

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

1.02

0.00

1.0

—

(3015531) Creatine kinase.macromolecular [Enzymatic activity/volume] in Serum or Plasma

0.00

0.0

1.0

—

0.0

—

(3029889) Paecilomyces variottii IgE Ab [Units/volume] in Serum

0.00

0.0

1.2

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

0.95

0.00

1.0

1.1

—

(40761895) Polymorphonuclear cells/100 leukocytes in Peritoneal dialysis fluid

0.00

0.0

1.8

—

(3026868) Penicillium brevicompactum IgE Ab [Units/volume] in Serum

0.00

0.0

1.2

—

(3014257) Rhodotorula spp IgE Ab [Units/volume] in Serum

0.00

0.0

1.2

—

(3004560) Lymphocytes [#/volume] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

0.99

0.00

1.1

1.5

—

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

1.02

0.00

7.1

6.4

umol/l

462.4

486.0

—

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

1.01

0.00

1.0

1.1

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

1.02

0.00

1.0

—

(3040661) Urea [Moles/volume] in Peritoneal dialysis fluid

0.95

0.00

7.1

6.0

mmol/l

16.8

17.3

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

0.95

0.00

1.0

1.1

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

1.01

0.00

1.0

1.1

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

0.88

0.00

1.0

—

(3022475) Manganese [Moles/volume] in Blood

0.95

0.00

1.6

1.5

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

0.98

0.00

1.3

1.1

nmol/l

196.5

240.8

—

Mortality – FinRegistry

↥

Association

Association between endpoint N14_PROSTHYPERPLA and mortality.

Females

No data

Males

Parameter	HR [95% CI]	p-value
N14_PROSTHYPERPLA	1.144 [1.06, 1.23]	< 0.001
Birth year	0.986 [0.98, 0.99]	< 0.001

During the follow-up period (1.1.1998 — 31.12.2019), 76532 out of 209249 males with N14_PROSTHYPERPLA died.

Mortality risk

Mortality risk for people of age

years, who have N14_PROSTHYPERPLA.

N-year risk	Females	Males
1	No data	0.175%
5	No data	1.063%
10	No data	2.672%
15	No data	4.985%
20	No data	8.298%

Relationships between endpoints

↥

Index endpoint: N14_PROSTHYPERPLA – Hyperplasia of prostate

GWS hits: 68

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Hyperplasia of prostate

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints